Our unit serves for children since infants till 18 years who undergo mostly allogeneic stem cell transplantation. Every year we take care about around 40 children and their parents. One family member (usually parent) participates during the whole day in the care for child and overnight sleeps in close dormitory. We therefore place the great emphasis on the education of parents companioning their children during the stay at unit and also with the aim to help them with transition from hospital to hope and outpatient care. At the very beginning parents pass through an interview with the attending physician to be informed about the treatment procedure, its benefits and possible risks. They sign the informed consent forms. From the beginning of hospital stay the individual theoretical and practical education in the hygiene issues and epidemiological service led by nurses continue. Well established and popular methods of parent education are periodic educational sessions organized once a week. Nurses train parents using slide show, practical demonstration and training. Particular emphasis is placed on the topics: Hygiene of the child and the regime in a sterile room; Oral care, mucositis and pain management; Graft versus host disease; Care for central venous catheter (CVC); Diet, dietary measures; Medication, drug interactions; etc. We apply various models for training CVC care, printed information, leaflets (low bacterial diet, food preparation, immunosuppressive drugs). Consistent education of parents is an important and integral part of procedures at our unit. Cooperation and active participation of the whole medical team -physicians, nurses, social workers, physiotherapists and psychologists is beneficent. Supported by: 503223-LLP-1-2009-1-TR-LEONARDO-LMP.
P1316 Haematology goes digital M. Bouwens, M. Goedhart Erasmus MC Rotterdam (Rotterdam, NL)
The electronic medical records (EPD) of the haematology department of the Erasmus MC. EPD is a virtual record that enables sharing of medical & nursing information. With EPD all relevant medical & nursing information can easily be shared in a secure fashion between diverse disciplines in the hospital. In the beginning of 2010 the haematology department started using the nursing component of EPD which is constructed according to the Gordon system. With the implementation of EPD the following become possible for the nursing staff:
Better access to up to date patient information from every work station
• Improved reporting quality due to consistent use of terminology & easy to read text (instead of handwriting) Reduced double registration of information Clear overview of patient information Uniform work process (thereby improving the quality of care) Better process support Information & reports available to all disciplines Positive effect on illustrating what interventions are conducted by the nursing staff Advantages:
Patient friendly (when a patient is seen by another doctor all known information is instantly available) Promotes coordination of care Time saving: it is easy to access from every work station Points for improvement:
Introduction of EPD in entire Erasmus MC Change in mindset by doctors and nursing staff; being open to reading information collected by other disciplines Development of a guide for the use of EPD for all nursing staff Agreement on access rights so that patient information is accessible to the correct disciplines Provision of more computers Continuous development of expertise Discussion: The expectation is that when EPD is implemented throughout the Erasmus MC that the quality of care will be safeguarded. The implementation of EPD is in the early stages therefore it is not possible to draw too many conclusions. However we can conclude that the implementation of EPD in the haematology department of the Erasmus MC has been accepted & experienced as a positive development by both doctors & nursing staff alike. Conclusion: The implementation of the nursing component of EPD within the haematology department of the Erasmus MC has led to an improved coordination & continuation of patient care. A. Grubisic, S. Markovic, M. Mrvos, O. Marjanovic, E. Radosevic Military Medical Academy (Belgrade, RS) Background: Tauro Lock TM-Hep 500 is a medical tool that is used to prevent infection with short-term and long-term central venous catheters (CVC) and ports. It consists of Taurolidina and 4% citri acid, and has anticoagulant and antimicrobial effects (acting on gram-positive and gram-negative bacteria,the fungi,and even the Vancomicin and Meticillin resistant Stafi lococ). It is used as prophylaxis because it effectively prevents colonization of planctonic level. Using Tauro-Lock has no side effects;there is no risk due to high concentrations (with the normal risk of unwanted bleeding due to use of heparin). If injected quickly into the bloodstream may give mild symptoms (metallic taste). Aim: Examine the effectiveness of Tauro-Lock in preventing CVC infections. Methods: The analysis included a total of 50 patients with various malignant hemopathies, 32 male and 18 female, mean 
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Conservation of central venous devices with tauro lock solution
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ages 32 (from 17-64 years),who were treated six months ago in the center for stem cell transplantation. We have compared the incidence of CVC infections and we have divided patients (pts) into two groups:group A where we have applied Tauro-Lock (3 ml in each arm CVC)-25 patients and group B where we have conducted standard prophylaxis (regular fl ushing). Compared groups did not differ in relation to age, sex and nature of primary diseases. Results: These analyses have compared the frequency of infections in groups and have showed signifi cant CVC common infections and we have divided patients (pts) in two groups. Comparisson between two groups in this analysis have showed signifi cant frequency of CVC common infections in group B compared to group A (6 /25, 24% v. s. 0/25, 0%, p <0,05). Conclusion: Using Taurolid/Citrate signifi cantly reduce the frequency and intensity of CVC infections and consequently the frequency of systemic infections in due to CVC caused by Cons and MRSE in our center for stem cell transplantation.
Complementary therapies
P1318
Therapeutic massage S. Reynolds Queen Elizabeth Hospital (Birmingham, UK)
Massage is 'the rhythmic and methodical stretching and compressing of the muscles and connective tissue through touch of the therapists hands' For people coping with cancer, massage therapy can be a powerful way to ease stress and anxiety, relive pain and therefore improve quality of life. In 2008 the Karen Morris Memorial Trust generously donated funding for a complimentary therapist for the Haematology Department at the Queen Elizabeth Hospital. It was decided a physiotherapist would be the most appropriate way of providing this therapeutic massage service, as massage is one of the key pillars of Physiotherapy practice. All patients under the care of the Haemato-oncology service have access to this massage service. In the past 12 months 43 general haematology/autologous Haematopoietic Stem Cell Transplant (HSCT) patients and 55 Allogeneic HSCT patients have utilised the service, with 558 treatments being completed in total. 60% of these treatments were for the allogeneic patients therefore it was decided to ask this group of patients to complete a questionnaire regarding their satisfaction of the service. 30 patients were asked to complete a questionnaire anonymously when they attended their outpatient appointment, which all agreed to do. We asked how the patients had heard about the massage service, 56% (17) had been informed about the service from a specialist nurse. Reasons for referral were varied with 60% (18) identifying a muscular problem or pain they were experiencing. 20% (6) mentioned they had massage treatments for relaxation purposes. All patients stated they had received an explanation about what was going to happen, had benefi ted from the service and all would recommend to another patient. Finally there was a free text box for comments, there were no negative comments received. Comments ranged from 'extremely good service, mental and physical benefi ts' to 'priceless'. This audit showed the service was well received and of great benefi t to patients.
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Extracorporeal photopheresis -A gentle approach to traditional GvHD therapy? S. Martin, B. Lang UKE (Hamburg, DE) What does ECP mean? ECP is a leukapheresis based immune modulating therapy. This gentle therapy with few adverse reactions is applied to patients with acute or chronic Graft versus Host Disease (GvHD).The photopheresis takes place outside the body. It aimes to treat overactive T-cells. A suppression of immune response can be achieved by the use of UVA radiation to T lymphocytes. An increased immune tolerance between donor and recipients cells is to be expected. The ECP's effi ciency mechanism has not been studied at all. It's assumed that the induced apoptosis of T-cell results in an immune supressive effect.
Steps of ECP Side effects ECP is in general a well-tolerated therapy. But patients report strong fatigue on the same or next day. Because of an increased sensibility to UV radiation and ray of sunlight respectively up to 24 hours after ECP, patients are advised to avoid sunlight, to use a sun block and to regard sunglasses UV protection. Infrequently occurring hypovolemic blood pressure decrease, which is easy to handle. Therefore a vital signs check at the end of each phase is obligatory. When indicated daily anti hypertonic medication schedule is to be adapted. Suffi cient hydration reduces hypervolemic. 2-12 h after reinfusion an incidental minimal increase in temperature becomes noticeable. This rise in temperature is not ralated to infectious complication. Potential side effect of ECP are infected PCV /CVC and hypertriglyceridemia. For this reason full-enriched parenteral nutrition is to be avoided. At University Medical Center Hamburg-Eppendorf (UKE) Germany At UKE we started in 2007 with 74 ECPs and now in just the fi rst 9 months of 2010 we have performed 349 ECPs. 47 patients in total got ECP since 2007. This graphic shows the results of ECP in cGvHD. Ca. 65% of our patients are in partiell remission and almost 10% in complete remission. Only less than 30 did not respond. An improvement will be achieved gradually -iIn case of chronic GvHD even several months. We nowt started ECP also in aGvHD.
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P1320 The consumption of natural therapeutics on haematological patients T. Lopes, M.T. Moreno Hospital Santa Maria (Lisbon, PT)
By observing what our professional performance gives us, we became aware that many Hemato-Oncology patients, to whom we provide care, have the habit to consume therapeutics obtained in other ways than through prescription. We feel the need to deepen the subject. We researched and visited natural products sale stores. We found that the sale of these products is done without the supervision of health professionals, they are easy to buy and are "free from risk or side effect". We were faced with diffi culties, which served as an incentive for us: the scarcity of data and bibliographic resources and the lack of appreciation of the problem. If the problem exists, it can't be ignored. This way, this study proves to be quite useful not only for the hematological patients, but also for nursing itself. We conducted a qualitative research study, using the Grounded Theory method. We used the nonprobability accidental sampling method. The research question was: "What are the factors that infl uence the consumption of natural therapeutics on hematological patients admitted to the Intensive Treatment Unit for Hematological Patients (ITUHP) and, on an outpatient care basis, to the Hematology Day Care Center?" The objectives of the study were: To assess the pattern of consumption of natural therapeutics on hematological patients, understand the motivations that lead hematological patients to consume natural therapeutics; Check if the pattern of consumption of natural therapeutics varies with social class. Our study variable was the consumption of natural therapeutics. The remaining data analysis, were some socio-demographic and population characteristics, such as gender, age, residence, educational level, profession, clinical diagnosis and inpatient versus outpatient. Twenty-eight interviews were conducted between January and May 2010, which eleven were admitted in ITUHP and seventeen in an outpatient setting.
Half of the sample admitted to have used alternative therapies, always aiming to complement the conventional therapies. Products consumed were usually recommended by friends or other patients with the same injury. Its effect was hardly proven. Of the 14 respondents who joined the alternative therapy, half did not told to his or her physician, usually for fear of negative opinion. This work was positive in that it raised awareness of this reality for the rest of the nursing staff team, this issue has been included in the initial patient assessment sheet.
P1321 Evidence for the use of chamomile in oral mucositis
F.T.M. Braga (1), R.C.C.P. Silveira (1), L.M. Garbin (1), A.C.F. Santos (2), E.C. Carvalho (1) (1)University of Sao Paulo at Ribeirao Preto (Ribeirao Preto, BR); (2)Bone Marrow Transplant Services of the Fundação Amaral Carvalho (Jaú, BR)
Oral Mucositis (MB) is a frequent complication among patients undergoing hematopoietic stem cell transplantation (HSCT) as a result of aggressive treatment regimen employed. However, its prevention and treatment are still controversial in literature. Chamomile is a medicinal plant which has been used for therapeutic purposes for centuries and has been employed in some TCTH services for prevention and treatment of MB. The reduction of infl ammation and the promotion of healing are included among its therapeutic properties, both mainly favored by fl avonoids and essential oil. This integrative literature review aimed to identify the evidence regarding the use of chamomile in the MB treatment induced by chemotherapy and radiotherapy. PubMed and Lilacs databases were searched and the descriptors mucositis, chamomile and adverse effect were used. The Selection criteria were: articles that addressed the use of chamomile as an intervention for mucositis, which were written in English, Spanish or Portuguese and published in the last 20 years. Eight bibliographic citations were identifi ed, three of which did not meet the established criteria. Thus, the sample consisted of fi ve articles. Concerning the level of evidence, one article was classifi ed as level 02 (randomized clinical trial), another as level 03 (quasi-experimental), two studies as level
S413 05 (one experience report and one case study), and one of them (literature review) did not fi t the levels of the classifi cation system adopted. As to the study population, in 02 articles the subjects were submitted to chemotherapy, in other 02 they were submitted to chemotherapy and radiotherapy, and in the last to radiotherapy. In 04 studies, results indicate the possible action of chamomile in reducing the severity of mucositis and in one article there was no evidence of signifi cant change. Regarding the formulation, the tea was used in 04 studies and chamomile extract in 01, but studies have not presented data related to evaluating the quality of the plant and/or quantifi cation of the active principles present in the formulation employed. Although the results suggest a possible action of chamomile in MB, there are a limited number of publications and the strength of evidences is low. Thus, further studies with experimental designs and presenting the chemical components of the formulation is required to support the use of chamomile for MB treatment.
Donor issues
P1322
Optimizing the search process for matched related donors typing A.-M. Berthelsen, J. Holder Rigshospitalet (Copenhagen, DK) Background: For referring hematology departments, tissue typing of possible matched related donors (MRD) has been a time prolonging and diffi cult process to overlook. This has caused a longer time frame to transplant for the patient. The coordination problems that have been related to search process are; is donor interested in being a donor; eligibility as a donor; have tissue typing been performed; and have the potential MRD been informed whether they are eligible or not as a donor. Methods: To identify key points for improving the search and typing process for MRD´s, a meeting was established for representatives from; the referring hematology departments at Rigshospitalet, the transplant physicians, the transplant coordinators, the Blood Bank; and the Tissue Type lab. The existing process was outlined and areas for improvement in the workfl ow of the MRD search process were identifi ed. The participants were divided into the following work groups:
Creating standard letters from referring physicians to possible MRD´s and Tissue type lab. Creating forms to collect donor health information sooner in the process to optimize the process.
Creating reply letters for MRD´s if they are a match or not. Rewriting donor information. Developing a visual diagram with an improved process for MRD search. Reviewing the search process for Matched Unrelated Donor (MUD) search in cases where a MRD is not available. Conclusion: The current work is still ongoing, however by now we experience that:
The search process has been shortened. The referring hematology department collect health-and personal data earlier in the process. The attention to whether the sibling eligibility as a donor or not have increased.
The collaboration between the different departments have been increased. Perspectives: So far the implementation process is ongoing at Rigshospitalet, Copenhagen. We are still working on implementing reply letters for possible MRD´s in the hope to improve the information level. Currently, the IT-department is developing a visual diagram, making it possible to follow the MRD search process. Likewise it will be possible to click on different levels in the search process and print out relevant forms. In the future this optimized process will be offered to other referring hematology departments.
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Search procedure for unrelated donor of haematopoietic stem cell in Slovenia P. Klancek (1), M. Mlekuz (1), I.K. Skoda Gorican (1), C. Flajs (2) (1)University Medical Center (Ljubljana, SI) ; (2)Blood Transfusion Centre of Slovenia (Ljubljana, SI) Hematopoietic stem cell transplantation (HSCT) has become the most successful treatment for various hematopoietic, mostly malignant diseases. For allogeneic HSCT it is essential to fi nd the perfectly HLA matched donor. Usually, the most appropriate donor is found among the patient's siblings. However many patients have no suitable HLA matched donor among family members and for those it is necessary to search for voluntary unrelated HLA matched donor in national and international registries joined in Bone Marrow Donors Worldwide (BMDW). Slovene national registry Slovenia Donor (SD) was established at the end of 1991 and is member of BMDW since 1992. At the end of year 2009 14.466 voluntary donors are included, 9836 of them are completely typed. In 2009 7 ( 0,07%) matched unrelated donors were located, 4 of those (0,04 %) for Slovenian patients and 3 (0,03%) for patients from abroad (6-0,06% HSC from peripheral blood and 1-0,01% from bone marrow). In 2009 98 HSCT were performed in our Centre; 73 (74,5%) were autologous and 25 (25,5%) allogeneic; 12 (48 %) were related and 13 (52 %) unrelated. Donor search starts with the patient's referral to HLA typing laboratory at Blood Transfusion Centre of Slovenia. At fi rst patient's siblings are typed and in exceptional occasions also other family members. If there is no appropriate family donor, the procedure of unrelated donor search starts. Decision is carried out by patient and physician together. The whole search procedure and selection of potencial donors is performed by SD registry which is a part of the Blood Transfusion Centre of Slovenia. When appropriate donor is found, confi rmation typing is performed and all medical examinations too, if the donor is from SD registry. Final agreement about the source of hematopoietic stem cell(HSC) (peripheral blood, bone marrow), harvest schedule and conditioning of the recipient is coordinated between Transplant centre, SD registry and Donor Centre by the responsible person of SD registry. SD registry also organizes transportation of HSC from Donor Centre to HSCT Centre at University Medical Centre Ljubljana.
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To what particular problem of the related donor does a clinical transplant coordinator pay attention to in Japan? M. Saigusa, T. Onda Tokai University Hospital (Tokyo, JP) Introduction: In Japan there are offi cial systems for registration, follow-up, and insurance related to the management of physical aspects when considering the wholly related donor. However there is no widely accepted donation guideline for related donor care. The majority of related donors are connected with the recipient's doctor because there are only 10 transplant centers that belong to the Clinical Transplant Coordinator(CTC) who works with related donors. Practitioners are facing the unique and intrinsic circumstances of related donors and the challenges they encounter. Japanese study reported that even if the related donors thought that they didn't want to be donor they didn't decline. Their thoughts are not externalized due to private problems or "family reasons" and little is known about the donor's specifi c hardships relating to adult sibling stem cell donor circumstances. Therefore we analyzed the hardships of the donor whom CTC had processed. To clarify the psychological and emotional aspects and the factors of the donor's hardship with this study, that pays attention to the view and work of CTC who care for the related donor, may help in the development of related donor care. Objective: The purpose of this study was to determine what kind of the particular hardships and their factors that sibling donors were confront with throughout in stem cell transplantation. Methods: A Modifi ed Grounded Theory Approach and a coding methods were used to analyze. Data for the analysis were 13case reports by 5 center's CTC where donor's hardships occurred in process of adult sibling donor. Results: The hardships of the sibling donor whom CTC identifi ed a concern;3 categories emerged to describe. 1) Donor had "Naturally feeling obliged to act". They were surrounded by "difference between the patient", "practitioners must seem natural" and "secret heartless" in blood relative standpoint during "approached seriousness situation suddenly". 2) Donor was unable to reconcile their own feelings with the perceived expectations of the family. It was caused in the standpoint as immediate family. Donor felt "leaving alone out in the cold" and struggle against expectations tactic rules of family and their own.
3) The donor can have a "feeling of isolation" caused by lack of consideration or recognition of their feelings through the donor process. Factors of donor's hardship that CTC identifi ed: The factors were emerged 3 categories "environmental" "system" "care". At the Children's Hospital at Westmead (CHW) Peripheral Blood Stem Cell (PBSC) collection is an essential part of transplantation for a variety of Paediatric malignant disorders. The paediatric patient presents its own range of challenges during an apheresis procedure including small total blood volume, anti-coagulation, blood volume shifts, vascular access and psychosocial concerns, Approximately 40 children per annum at CHW have an autologous PBSC collection. This is for a range of uses either-protocol specifi c or for rainy day / back up harvest. The age range -6 months -17 years Weight range -4.5kgs ->100 kgs The collection commences once the peripheral CD34 count is >20 x 106/l, and the aim of the collection is to obtain a minimum of 2 -5 x 10/6 CD34+ / kg or as defi ned by the patient's protocol. Over the past 14 years the CHW has performed approximately 450 procedures successfully using the -Automated PBSC procedure on the COBE ® Spectra™ version 6.1. With the introduction of the Mononuclear cell MNC procedure on the Spectra Optia ® Apheresis System at the end of 2008 we purchased this device at the beginning of 2010. With the latest software update to version 5 in August 2010 we commenced using the Spectra Optia ® Apheresis System for our MNC collection procedures. To date we have performed 10 separate collections on children ranging from 11kgs to 70 kgs with a range of malignant diseases. We will present the data on these patients and compare the results to similar patients who were collected using the COBE ® Spectra™, outlining the length of the procedure, amount of anti-coagulant required, and reviewing the collection effi ciency. In addition we will discuss the challenges faced by the Apheresis nursing staff when using a new device and mastering all the technical aspects to minimise complications and optimise the collection process for this challenging group of patients.
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Impact of new therapies on patient care
P1326 Use of rituximab in treatment of steroid refractory chronic graft-versus-host disease in post-allogeneic haematopoietic stem cell transplantation S.Q. Chui, Y.K. Guan, T.C. Ong, K.M. Chang Hospital Ampang (Selangor, MY) Introduction: Chronic Graft Versus Host Disease (cGvHD) is a major cause of long term morbidity and mortality among post allogeneic haematopoietic stem cell transplant patients. Steroid refractory cGVHD has no standard treatment and most treatments have limited effi cacy. Objective: To attempt to study the effi cacy of Rituximab in steroid refractory cGVHD patients. Methods: A retrospective review of all allogenic haematopoietic stem cell transplant patients of Department of Haematology Hospital Ampang from 1999 to 1st September 2010 was done and patients who were treated with Rituximab for cGvHD were selected and analysed. Data collected included patients' demographics, transplant details, cGVHD details and outcome. Outcome and survival was assessed based on status at 1st September 2010. Results: There were a total of 6 patients who underwent Rituximab treatment. 1 patient was not analysable as she stopped treatment only after 2 doses due to unacceptable reaction to Rituximab. 4 had partial response where their corticosteroid doses were able to be tapered. 1 had no response. There was 1 death due to secondary AML which was not likely treatment induced. Skin cGvHD appear to respond to Rituximab treatment. Conclusion: Rituximab seemed to be effective in controlling cGvHD with steroid sparing effect in certain patients. Most of our patients with skin manifestation had some response. Timing of Rituximab intervention and type of cGVHD appear to infl uence the outcome of treatment. ) is an antagonist of α-chemokine receptor CXCR and one of the new additions to Haematology; it is used as a stem cell mobiliser. CXCR4 α-chemokine receptors are important in hematopoietic stem cell homing to the bone marrow and in hematopoietic stem cell quiescence. It is indicated in combination with Granulocyte Colony Stimulating Factor (GCSF) for Peripheral Blood Stem Cell (PBSC) collections in the Multiple Myeloma (MM) and Lymphoma patient group with a poor mobilisation history. Method: In our organisation, data was collected prospectively. 14 patients received Plerixafor for PBSC collection between May 2009 and September 2010. All patients except one met the criteria prior to treatment (White Blood Count> 2.5 x 10 9 /L, Absolute Neutrophil Count > 1.5 x 10 9 /L, Platelet> 85 x 10 9 /L, Serum Creatinine < 1.5 mg/dL, Aspartate transaminase (AST), Alanine Transaminase (ALT), Bilirubin < 2 x ULN with no evidence of Hepatitis B and C. One patient had low a platelet count. Patient demographic data is shown in Table 1 . Result: All patients received four consecutive days of GCSF 10 μg/kg prior to Plerixafor. Plerixafor was given 10 hours prior to the PBSC collection, GCSF was repeated one hour prior to PBSC collection on the morning of the collection. All patients received 0.24 mg/kg/day of Plerixafor. There were no side effects observed. Only one patient required a second dose of Plerixafor. For all cases, the target CD34+ count was 4 x 10 6 cells/kg of recipient body weight. Two patients responded extremely well with a CD34+ count of 21.79 x 10 6 cells/kg and 15.16 x 10 6 cells/ kg achieved and six patients achieved the target of 4 X 10 6 cells/ kg or above. However seven patients failed to achieve to reach the target of CD+ 34 X10 9 cells/kg. Six of these patients had adequate amount of CD34 counts for an autologus transplant. Only one patient failed to mobilise any CD34+ cells at all. Conclusion: According to this study Plerixafor has improved PBSC collection outcomes with one exceptional case. Plerixafor defi nitely made a positive difference to 54% of our patient
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S416 group and 40% of our patients had enough cells for an autologus transplant. However, results are inconclusive due to the small sample size in the study. Ongoing studies with new patient experiences are needed. More than one dose of Plerixafor maybe required for heavily pre-treated patients who are historically poor mobiliser of PBSC collections.
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Comparative study of oral solutions in the prevention/ treatment of mucositis M. Felício, A. Santos, I. Cerqueira, G. Duarte Hospital Sao Joao, EPE (Porto, PT) Introduction: Oral mucositis (OM) is one of the most common and debilitating side effects induced by treatment with cytostatics, especially in patients undergoing hemato-oncology auto-transplantation of Peripheral Blood Progenitor Stem Cells (PBPC), where doses are used for intensive chemotherapy. In these cases, the OM is severe, requiring the use of large amounts of opioid analgesics for effective pain control. In our unit, by the end of 2009 conventional solutions (consisting of amphotericin, sodium bicarbonate and lidocaine) were used to rinse, which mitigated the pain. Currently a supersaturated solution of calcium phosphate (Caphosol) is used. To assess the benefi ts of the solutions used, all patients are subjected to monitoring of pain intensity by a numerical scale of pain assessment. Objectives: Analyze/compare the effects of oral solutions used for the prevention/treatment of OM in patients undergoing autotransplantation of PBPC.
Methodology: Comparative study to determine the most appropriate oral solution in the prevention/treatment of OM. The sample consists of a total of 20 patients who underwent a conditioning regimen for auto-transplantation. 10 patients used the conventional solution for the period January-July 2009 and the remaining 10 used the solution "Caphosol" in the same period in 2010. Note that the patients selected in these 2 periodes had the same diagnoses. The variables include: sex, age, diagnosis, grade of OM, maximum degree of pain and administration of intravenous morphine (IV). Results: The sample consistes in 75% men and 25% women with a median age of 41 years whose diagnoses are 50% lymphoma, 30% acute leukemia, 20% multiple myeloma. After examining the variables it was found that patients who used conventional mouthwashes showed 30% of Grade IV OM, 50% Grade III, 20% Grade II, having been referred to the maximum degree of pain 30% Grade 10, 30% Grade 8, 20% Grade 7, 10% Grade 6, 10% Grade 5, where 100% required IV morphine as adjunctive therapy. The patients who used the "Caphosol", developed 40% of Grade II OM, 40% Grade I, 20% Grade 0, were referred to the maximum degree of pain 20% Grade 5, 30% Grade 3, 30% Grade 1and 20% Grade 0. Thus only 40% required administration of IV morphine. Conclusion: According to the results it was concluded that, after using the solution "Caphosol" the degree of OM reduced such as the use of morphine in controlling pain intensity.
[P1327] S417 P1329 Observational retrospective study on the incidence of haemorrhagic cystitis and genital lesions in allogenic THSC patients treated with foscarnet M. Mancini, V. Matozzo, D. Previtali, F. Ciceri IRCCS San Raffaele (Milan, IT) Introduction: CMV is one of the most important infective complications following allogenic transplant of hemopoietic staminal cells (THSC), with a negative impact on the transplant outcome. Sodium Foscarnet is a systemic antiviral drug active against CMV infection after allogenic THSC. Foscarnet has a well known irritant local effect; Since Foscarnet is excreted in high concentrations through the urine, it might lead to genital irritation or ulceration (1-10% of treated patients) and hemorrhagic cystitis (10-40%). Objectives: determine the incidence of hemorrhagic cystitis and genital lesions (irritation or ulceration) in allogenic THSC patients treated with Foscarnet. Methods: monocenter, observational, retrospective study. Inclusion criteria: all consecutive allogenic THSC patients treated with Foscarnet between January 2009 and October 2009. Results: during the time period indicated above, where analysed the clinical records of 59 allogenic THSC patients (46 males and 13 females), treated with Foscarnet. The mean treatment exposure with Foscarnet was 14 days and the infusion of every single administration was given over 130 minutes. As a prophylaxis for hemorrhagic cystitis and genital lesions, all the patients were treated with: hyperidration and cleaning of the genital area with Euclorina 3% after every urination. The incidence of genital lesions and hemorrhagic cystitis was respectively of 29% and 37%. The 12% of the patients showed both side effects at the same time. The genital lesions appeared in average after 8 days of treatment, while the hemorrhagic cystitis after 5 days; the duration was in average 15 days for both side effects. In 30% of the patients the treatment was suspended due to the onset of side effect. Conclusion: the genital lesions were felt, either by the patient and the hospital staff, as one of the most "complicated" side effect of the Foscarnet treatment and in most of the cases represented the main dropout reason. Further studies would be needed to establish the correct relation between the appearance of hemorrhagic cystitis and the prevention of both those two side effects.
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Paediatric experience in low-level laser therapy in the prevention of oral mucositis N. Montmaneix, A. Chausset, C. Sozeau, E. Merlin, C. Duclos, J. Kanold CRCTCP, FR) Oral mucositis is a common adverse effect of chemotherapy and total body irradiation (TBI). The local and systemic treatments are little effective and limited by their side effects. Recently the use of low level laser therapy (LLLT) is proposed as a local preventive or curative treatment for oral mucositis. In children, only one study was performed in prevention of oral mucositis with 4 J/cm² (Cruz, Pediatr Blood Cancer 2007) . In our center we have compared LLLT at 2 J/cm² (group A) versus 8 J/cm² (group B) in a prospective controlled study. Eleven patients, programmed to be transplanted (7 autografts and 4 allografts), were included in the study from June 2009 to January 2010. They were initially treated for solid tumors (n=8) and haemopathies (n=3). Laser was applied from D1 to D5 of conditioning regimen: chemotherapy (n=8) or chemotherapy + TBI (n=3). Procedures were performed by a physician as well as a nurse during an average duration of fi fteen minutes. The preliminary results demonstrate: 1) that these sessions are well tolerated, even if they require the child to keep his mouth opened and to wear opaque safety glasses, 2) the feasibility is well considered whatever age, 3) the immediate tolerance is excellent whatever dose and age, 4) this study shows no difference between 2 J/cm² and 8 J/cm². However the most limitation of LLLT use bases on asepsis technical constraints, in particular for realization of the sessions in paediatric germ-free chambers.
Outpatient developments
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The work of a diagnosis-specifi c team nurse: benefi ts and challenges P. Lindroos Kolqvist, C. Dahl Hammarstedt Sahlgrenska University Hospital (Gothenburg, SE) Receiving a hematological diagnosis can, and usually will, entail a long treatment period for the patient that can be very physiological, mentally and emotionally demanding. The nurse who meets with the patient on a regular basis has an important role in supporting, informing and leading the patient through the treatment and into the new life situation. In 2003, a development project began at the department of hematology with the purpose of improving the competency, continuity, quality and availability. The project led in 2005 to the outpatient unit being divided into fi ve diagnosis specifi c teams with a responsible team nurse assigned to each team. At the launch, this team concept within hematology was a fairly new approach in Sweden. The purpose of this poster is to describe the role of the team nurse in the outpatient unit and identify the benefi ts and challenges of working in a diagnosis specifi c team. The team nurse is responsible for the care of the team's patients within the outpatient unit. The daily work consists of the usual nursing duties, like giving treatments and transfusions, as well as administrative duties and a care development role within the team. The team nurse's frequent contacts with the patient lead to intimate knowledge of the patient's illness, history and ongoing treatment. The team nurse also functions as a link between the patient and the physicians assigned to the team and will often become the support and spokesperson for the patient. The team nurse develops a deeper knowledge through the diagnosis and treatment of the team's patients which in turn increases the engagement, interest and unique understanding of the specifi c problems, care and needs of the patient group. The work as a team nurse can be challenging as fewer nurses have knowledge about the team's patients. It can lead to an increased psychological workload due to the support needs of the patients. The team nurse's responsibility to the team and its patients can lead to increasing demands from colleagues, physicians and supervising staff. Our opinion is that the introduction of diagnosis specifi c teams with a responsible team nurse has contributed to increased availability and a better quality of care and, for the specifi c patient, it has given a better sense of security and continuity in the care. For the team nurse, the team approach can provide the benefi ts of increased workplace satisfaction as well as create development opportunity in the fi eld of hematology. (Huddinge, SE) At the Centre for allogeneic stem cell transplantation unit (CAST) Karolinska University Hospital, patients can choose between home and hospital care. Studies from CAST (2002 CAST ( , 2006 reported that homecare during HSCT reduced incidence of infections, acute GVHD and improved treatment-related survival. To further investigate these two caring contexts the present study aim to evaluate and compare patients satisfaction and support from the healthcare staff when receiving care in home or hospital during the pancytopenic phase. Patients and methods: 41(20 female, 21 male), median age 54 (32-67) years, transplanted 2006-2009, participated in the study. 19 patients received home care and 22 hospital care. 8 patients in the homecare group were at home the whole caring period. Both groups had a median length of stay of 24 (15-59) days. 32 patients were married/cohabitant. AML (n=17) was the most common diagnose and 36 patients received PSCT. The Sympathy-Acceptance-Understanding-Competence-questionnaire (SAUC) was used to collect self-reported data on patient's satisfaction and support. Data were collected at discharge from the transplant unit. The SAUC contain 46 questions divided into 3 general domains; person-support, self-support, self-perspective. Self-perspective contain 4 areas; life plan, repertoire, internal and external environment. A mean score (ranging from 0-7) is calculated for each domain/area -high score indicated better patient satisfaction. Preliminary result: Patients reported high satisfaction, regardless of caring context, in 5 of 6 domains/areas; self-support [md 6 (4-7)], self-perspective; life plan [md 6 (3-7)], repertoire [md 6 (4-7)], internal [md 6 (3-7)] and external environment [md 7 (5-7)]. Patients reported a lower satisfaction [md 5 (4-7) ] in the domain person-support. No signifi cant differences were found between the homecare and hospital care group in the 6 dimensions/areas. Conclusions and clinical implications: The study shows the patients are highly satisfi ed with the care and the support regardless of context. The clinical experience is that patients cared for at home are more satisfi ed than patients treated at hospital however the measurement used in this study do not support this. Other factors need to be studied to explain the differences in clinical experience and patient reported satisfaction.
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Cyclophosphamide priming with GCSFf mobilization: a change in practice for autologous transplants in multiple myeloma R. Nicholson, N. Banks Manchester Royal Infi rmary (Manchester, UK) Autologous stem cell transplantation is standard care for patients with multiple myeloma in order to rescue the bone marrow following high-dose chemotherapy. For this, a minimum of 2x10 6 /kg CD34+ cells are required per transplant procedure, aiming to harvest suffi cient stem cells for two transplants in the younger patients. Standard UK practice is the use of cyclophosphamide 2g/m² followed by granulocyte colony stimulating factor (GCSF) injections to mobilise stem cells from the bone marrow into the peripheral blood where they can be collected via apheresis. Until July 2008 patients had received either 300mcg Filgrastim or 263mcg Lenograstim per day until harvest. However, suboptimal harvest yields highlighted the need for a change in practice. From July 2008 the dose of GCSF was increased to 10mcg/kg in an attempt to maximise harvests.
In this study we collected data from a total of 80 patients who had undergone stem cell harvest. Of these patients 40 received one vial of GCSF from july 2006-july 2008 (Group 1) and 40 received 10mcg/kg from july 2008-july 2010 (Group 2). Group 1 had a median harvest yield of 3.54x10 6 /kg CD34+ cells, most of which required two harvest days suffi cient for only one transplant procedure. In comparison, group 2 had a signifi cantly higher median yield of 6.28x10 6 /kg which was achieved within an average of 1 collection day. The results have shown that by increasing the dose of GCSF we can more effectively mobilise stem cells, ensuring a high enough yield for two transplant procedures whilst most patients only required one day of harvest as opposed to two days. This has not only had a positive impact on patients' quality of life but has also reduced nursing and laboratory staff time and resources. In conclusion, prior to this change in practice harvest results were not consistently yielding adequate stem cells for the standard two transplants. However with increased dosing of GCSF results are far more encouraging, consistently allowing the collection of more than the required number of stem cells for two transplants. Furthermore this is now being achieved over fewer days, ensuring that patients have a shorter hospital stay. It is clear that this change in practice has been successful in improving overall outcome and could be used as a step towards changing mobilisation on a wider scale.
Patient information and education
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Cost analysis comparison between 6/6 HLA matched related donor haematopoietic stem cell transplantation and hypertransfusion in severe thalassaemia W. Panthangkool Ramathibodi Hospital (Bangkok, TH) The only curative treatment of severe thalassemia is hematopoictic stem cell transplantation (HSCT). However, cost of HSCT procedure is expensive. Conventionally, patients with severe thalassemia regularly receive blood transfusions for improving their quality of life. Although the cost of each blood transfusion is not high but the accumulative expenses of this treatment may be more expensive than HSCT. The objective of this study was to compare the cost of HSCT and regular transfusions in children with severe thalassemia. We examined the direct costs of treatment in children with thalassemia underwent 6/6 HLA matched related donor HSCT at Ramathibodi hospital between 1992 and 2008. The direct costs included the expenses of pre HSCT evaluation, admission for HSCT, complications, and other related procedures. The cost of hypertransfusion program was determined by the National Healthy Security Offi ce on the year 2006. The costs of treatment of thirty seven thalassemia children underwent HSCT were evaluated. A median time of follow up was 14 months (range,1.8-63.6 months). The mean cost of HSCT was EUR 22,788 per patient whereas the cost of hypertransfusion was EUR160,780 ( EUR 1=41.05 THB ) at 30 years of age. The majority of expenses for HSCT was paid for medications and related products.
In conclusion, our data demonstrated that the cost of HSCT was lower than hypertransfusion in children with severe thalassemia.
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Information on HSCT: creation of a guide M. Ruiz-Seixas, T. Gómez-Férriz, D. Álamo-Púlgares, M. Rey-González, N. García-Lafuente Hospital Universitario Virgen del Rocio (Sevilla, ES) From the time a patient is suggested to have a haematopoetic stem cell transplant, to their admission to the transplant unit for the procedure, they receive information about the procedure, complication and results.The information provided is based on the patient and his/her family's demand, which results an uneven quality and quantity of information.Inadequate information about the transplantation process creates stress and anxiety in both the patient and his/her family. The diagnosis of "insuffi cient understanding" and "anxiety" are the most prevalent during the transplantation. There is a real need for change in the type and content of the information, as well as where and when to offer it It would be useful to have a graphical tool to complement and reinforce the verbal information given to the patient/family, and to help to normalise and standardise this information Aim: Improving the patient/family's knowledge of the HSCT procedure and treatment and related information The patient can access it whenever it is needed, in a safe, lowstress environment for better understanding, and where any questions can be answered. It is a useful tool for nursing. It unifi es criteria and results in an improvement in the quality of care.
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Need + information = satisfaction S. Vieira, D. Monroe, M. Librojo, N. Amin, A. Donkin, M. Madziwanzira, H. Chipuhdla, L. Porin, L. Chavez, M. Palomar, C. Bernardez The Trustee of London Clinic (London, UK) Introduction: Over the last decade, information for cancer patients has become increasingly more importance. The very nature of the cancer requires patients to learn about their disease in order to cope with the consequences of treatment and in inform the decision making process. It is therefore vital to provide enough information for patients and relevant others. People/patients vary in the amount of information they require. Evidence suggests that some patients do not want very much information about their diseases or any treatments. This study aims to explore how much information our patient group wants to know and how much information our team provides to the patients. Method: A questionnaire was prepared to collect data on how much information was given to patients on three different stages of their treatment plans. These stages were: on admission, during their inpatient stay and on discharge. A fourth section was added, to investigate other information need patient felt required. The questionnaire was used between May 2010 till October 2010, total of 50 questionnaire. Outcome of these data collection is shown in Table I Table I ). During in patient period was the lowest stage where information provided. It is important to bear in mind that the haematology patient group undergo long period's hospitalisation. The data collection tool was given on discharge; therefore data might be lost due to poor recall of the information. Results also showed our patient were happy about the information they were given especially on discharge as most aspect of information covered (See Table I ). Conclusion: Knowledge assist informed decision making in the haematology patient group as healthcare professionals it is our duty to provide the information patients need. The question remains how much information patient require. This study aimed to explore the information needs of our patient group as well as a performance audit. The results concluded that our centre performed well on provision of information on admission and discharge although more work is required during the patients in patient period.
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Oral care of children with cancer P. Sällström, A. Pietikäinen Helsinki University Central Hospital (Helsinki, FI) Oral care in cancer patients is of paramount importance because of their immunosuppression. Our department has for years sought to develop cancer sick children's oral care. In 1998 a group of nurses made a manual for oral healthcare with the help of a dentist and a hematologist. This leafl et, which have been updated in 2010, is a good support in children's oral care for both parents and staff. There was a clear need for integrating our management practices. On our ward is a lot of employees. This creates its own problems in developing and in maintaining integrated care policies. The leafl et is good in preventing problems which appears when everyone has their own ways of performing oral care. The leafl et contains not only information on the use of various products but it also provides guidance for various situations, such as care during radiotherapy and stem cell transplantation (SCT). The booklet deals also about the importance of normal oral hygiene. We had previously only a few oral care prod-ucts in use, but over the years the product range have expanded and diversifi ed. On our ward is a habit that the nurses take care of children's mouths when they are most sore, to support parents' ability to cope. At the same time we are also able to revise the condition of their oral mucosa and evaluate whether the given treatment is appropriate. On ordinary chemotherapy course the children uses for oral health treatment either an ordinary toothpaste and brush, or alternatively products containing chlorhexidin. For children undergoing a SCT we have a special paste, made by our hospital pharma-cist's, containing fl uoride and chlorhexidin. On our ward patients undergoing a SCT are not allowed to use normal toothbrushes. Instead they are advised to use either a special superlon mold or -stick for extra gentle tooth washing. In addition to the toothpaste majority of patients uses antifungal products, either as a paste or mouthsoluble tablet. Older children who already know how to fl ush their mouths are using a solution that helps maintaining the condition and healing the damages already appeared on the oral mucosa. Although our ward have had for years instructions for children's oral healthcare, we do not have a classifi cation for evaluating the condition for mucosa. It has also never been studied what kind of impacts our treatments and current practices have. A study like this would be a major challenge for our ward in the future.
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Project of patient information and education: an experience in a single haematological institution for improvement of quality of assistance M. Piumatti, B. Castellino, S. Pautassi, A. Ghiglia, A. Cavallo, D. Rapezzi, D. Mattei, A. Gallamini S. Croce E Carle (Cuneo, IT) Introduction: nurses, physicians and psychologists have an important role in instructing and informing patients upon hospital admission. All these health operators should explain at once the complex organization and the specifi c behavioural rules in a Positive-Pressure fi ltered-air (PPFA) ward to a patient just diagnosed as affected by a potentially life-threatening disease. Objectives: to provide patients and their relatives with a practical, easily understandable, information/instruction leafl et on rules for PPFA unit admittance and stay and on diagnostic/therapeutic procedures related to the different neoplastic disorders most frequently admitted to PPFA ward. Material and methods: we created 2 leafl ets: 1 for the double room (simple fi ltered air system) and 1 for the single one (PPFA). Both leafl ets are edited with different sections/chapters: ward presentation, general ward organization rules (visitors timetable), ward services/opportunities (psychological and religious assistance, library, internet connection and TV/movie entertainment), daily activities, kitchen access, rules/rationale for antimicrobial prophylaxis, basic instrumental and blood tests informations, dictionary for haematological neoplasms, rules for ward admission, nutrition advices, room characteristics, visitors behaviour rules in the rooms (double/single one). An anonymous questionnaire was provided to patients along with leaflets. Based upon patient replies we recorded the satisfaction index (SI), using a number scale (0 bad-10 good). Results: the male-to female ratio was 1/1 (total number=20). The education level (15% primary, 25% junior, 50% senior high school, 10% degree), age (30% 20-30 years; 15% 41-50; 35% 51-60; 15% 61-70; 5% 71-80) and social welfare were not infl uent on SI. The overall SI recorded for all the booklet sections was: grade 8 in 35%, grade 9 in 30% and grade 10 in 35%, respectively. In detail the overall SI was: 33,3% 10, 41,7% 9, 25% 8 for patients at fi rst admittance (n=12; 60%) vs 37,5% 10, 12,5% 9, 50% 8 referred to the latter admittanced patients (n=8; 40%). Conclusions: despite the small number of patients enrolled in this study and the short period of analysis, we can conclude that the present leafl et turned out as a useful educational tool, mainly for patients at fi rst admittance. We decided to continue with booklet and questionnaire distribution to all the patients upon hospital admittance, and to provide them also to Day Hospital patients.
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Bridging the gap: giving information to young people undergoing bone marrow transplants using modern media J. Armoogum, E. Cathcart, E. Cazenove, C. Knott, N. Mathambo, L. Tompsitt, J. Vevers, M. Wall University College London Hospital (London, UK) Further to award winning presentation at EBMT 2010, University College Hospital London Children's & Young Peoples Cancer Service continue to review delivery of information to young people undergoing bone marrow transplant (BMT). Innovation grant awarded from Foundation of Nursing Studies (FoNS) to develop project. Project objectives: 1) Evaluate current method of information delivery 2) Produce pre-BMT information book specifi cally for adolescents 3) Further develop information DVD 4) Create internal social networking site. Objective 1 data presented here. Method: Postal questionnaire sent to all adolescent patients who had undergone BMT in last 4 years (n=20). Included 12 questions and based on previously published survey. Participants informed study was anonymous and participation, or not, would not impact future care. Participants indicated if they were patient or parent. Quantative data analysis performed. Results: 7 completed questionnaires received, 35% response rate. 3 (43%) patient respondents, 3 (43%) parents and 1 (14%) did not indicate. 86% (n = 6) felt amount of information received pre BMT was 'about right' but 50% (n = 3) did not read information book and 1 did not respond. Young people thought book was too much information and should be condensed but parent comments were positive. 71% (n = 5) thought verbal information received pre BMT was helpful and all (100%, n=7) felt they received right amount of information about infections, readmission, mouth care, personal hygiene, physical activity and how they would feel. 29% (n=2) wanted more information about risks of BMT, nutrition and emotional wellbeing. 1 (n=14%) wanted more about graft versus host disease. Parent respondents felt information given openly, honestly and with compassion but would like to watch DVD of past patients or have opportunity to talk to them. Discussion: Some patients had not read any or part of book due to length and complexity highlighting importance of producing condensed adolescent version. Respondents indicated watching DVD or meeting patients and sharing experiences would be useful confi rming potential benefi t of DVD and internal social networking site as part of information giving and patient support. Conclusion: Young people and parents willing to put own experiences forward to support and inform others. Results of survey show young people require information presented in adolescent-friendly format supplementary to standard JACIE accredited book.
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Long-term complications of Hickman catheter in children undergoing haematopoietic stem cell transplantation S. Sirireung Ramathibodi Hospital (Bangkok, TH) Background: Hickman catheter has been widely used in patients undergoing hematopoietic stem cell transplantation (HSCT) for delivery of medications, blood products, parenteral nutrition, and stem cells and drawing blood samples. However, catheter-related complications are frequently found during their uses including which include infection, thrombosis, and catheter migration. To prevent these adverse events, our institute has established an educational program for caregivers taking care of the central lines after being discharged from the unit.
S422
Objective: To determine the types and incidences of catheterrelated complications in children undergoing HSCT. Methods: We retrospectively reviewed children undergoing HSCT at our institute between January 2004 and December 2008. Demographic data, type of HSCT, complications of Hickman catheter and reasons for catheter removal were recorded and analyzed. Results: Eighty one patients with a median age of 9.6 years (range, 0.5-16.7 years) were enrolled in the study. The diagnosis included malignant (n=35) and non malignant diseases (n=46). Most of them the children received underwent related HSCT. The median of catheter-indwelling day was 321 days (range, 27 and 711 days). The catheter-related complications occurred in 28 patients (34.6%). Catheter-related sepsis was found in 10 cases (12.3%). Mechanical complications were identifi ed in 14 cases, including thrombotic occlusion, dislodgement, fracture and pinch off syndrome. The catheters were removed due to elective decision, sepsis, tunnel infection, occlusion, dislodgement, and fracture. No catheter-related death was found. Conclusion: In this study, one third of children undergoing HSCT experienced catheter-related complications. Both infectious and mechanical complications were found equally.
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Feasibility and safety of donor outpatient self-administration of plerixafor for mobilization of peripheral blood stem cells B. Patiño, M.T. Peralta, E. Fort, M. Arnan, G. Ortí, I. SanchezOrtega, R. Duarte Institut Català d'Oncologia (Barcelona, ES) Plerixafor enhances mobilisation of peripheral blood stem cells (PBSC) in combination with G-CSF in patients with lymphoma and multiple myeloma. During clinical development, safety precautions restricted plerixafor administration, normally late in the evening, to be performed under medical supervision in a hospital setting. Such requirements may be diffi cult to accommodate outside clinical trials. So, following FDA and EMEA approvals, the analysis of feasibility of plerixafor self-administration by the donor in an outpatient setting has practical consequences for real life use of the drug. We present our experience in fourteen patients (7 men; 11 non-Hodgkin lymphoma, 2 Hodgkin lymphoma, 1 myeloma; median age 56, 36-65; weight 76, 54-89) who have undergone outpatient self-administration of plerixafor plus G-CSF for PBSC mobilisation between july 2009 and november 2010. All patients followed our training and supervision program both for plerixafor and G-CSF, including: 1) education on subcutaneous administration by a transplant nurse specialist, 2) reinforcement by the hospital pharmacy outpatients staff at time of initial collection of GCSF injections and at time of collection of plerixafor prepared on the day of administration following results of PB CD34 levels which trigger plerixafor indication in our practice, 3) telephone contact with transplant nurse specialist during working hours and with on-call physician available 24h for out-of-hours events, and 4) clinical evaluation by a physician the morning following plerixafor administration at the apheresis centre and referral to outpatients transplant clinic if required. All patients completed treatment without any severe adverse events, in particular, no cases of shortness of breath, severe allergic or anaphylactic reactions. No one required to contact the transplant nurse specialist or the on-call system. Only fi ve patients reported mild injection site redness and/or itching, diarrhoea, bone pains, and weakness. Ten of these fourteen patients (71%) successfully collected enough PBSC to proceed to autologous HSCT (median 4.05 x10 6 CD34/kg, 2.2-6.7). In conclusion, our experience suggests that plerixafor self-administration by the donor is feasible and safe, can rely on specifi c training and monitoring in an outpatients basis, and is likely to have practical benefi ts for donors and healthcare facilities in terms of real life implementation of this novel agent. E. Bertrand, N. Contentin, S. Porcheron, S. Collard, H. Tilly Centre Henri Becquerel (Rouen, FR) In 2003, the French « Plan Cancer » included "Announcement System" to improve information delivered to patients at special moments of their disease. Simultaneously, our team was involved in JACIE's accreditation process, a special time to fi x the ways we worked. Bone marrow transplantation announcement is a particular special moment in patient's life. In order to achieve legal and quality expectancies, we defi ned specifi c "Bone marrow transplant's announcement system" consisting in:
P1342 Allogeneic transplant informations delivered by the coordinator nurse
Medical and nurse jointed consultation where BMT's medical aspects are developed Specifi c nurse consultation. This nurse consultation consists in;
Re-explanation of conditioning regimen, aplasia, infection's prevention measures, immunosuppressive treatment Hospitalization's organization (personal effects, sake of hygiene, visitors…) Time out's anticipation and back home Bone marrow transplantation unit's visit Handing allograft's book in to the patient Patient and family education This interview allows to patient and his close relatives specifically dedicated time to questions. Each consultation benefi ts from traceability in medical fi le, available for every nursing taking care of the patient. Bone marrow transplant's announcement system has been evaluated. Nurse's participation to medical consultation increases information's continuity. Patients are satisfi ed having a preferential interlocutor. Treatment's re-explanation if often needed. Unit's visit plays hospitalization down. This global approach takes home ground into account. Allograft's book collects advises for daily life. Today, 100 % of our allografted patients benefi t from this consultation and we're extending this procedure for autografted patients. To conclude, this experience improves quality's life for our patients. So we decided to set up announcement from the initial care of our patients, treated for acute leukaemia, lymphoma and myeloma.
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The nursing management of ADA-SCID children treated with gene therapy M. Casiraghi, L. Callegaro, M. Palumbo, S. Marktel, A. Biffi , M.P. Cicalese, F. Ferrua, M.G. Roncarolo, A. Aiuti, C. Soliman San Raffaele Hospital (Milan, IT) Background: From 2001 till 2008 a dedicated medical-nurse team at the Pediatric Immuno-Hematology Unit treated with Gene Therapy (GT) 14 patients affected by severe combined immunodefi ciency (SCID) due adenosine deaminase (ADA) defi ciency. Patients were treated at a median age of 1.7 years with an infusion of autologous CD34+ bone marrow cells transduced with a retroviral vector encoding ADA, after nonmyeloablative conditioning (Aiuti et al, NEJM 2009) . Aim: To describe the nursing management of ADA-SCID children treated with GT during the fi rst approach in the clinics, hospitalization and follow up. Moreover, to underline the nursing role for planning, implementation and evaluation of adequate intervention to prevent infections, with involvement of families. Method: The nursing assistance was carried out through the logic of total care and the centrality of the person and family
during the clinical process. The Primary Nursing was the method applied and the clinical activity was carried out through the Evidence Based Practice. The instruments used to reach the objective include: nursing documentation, health education, educational brochures, and translated facilitated poster for the communication in 5 languages (Italian, English, French, Arabic and Turkish). Results: The experience with patients and families combined to the theoretical-practical nurses training permitted to elaborate a specifi c nursing plan for ADA-SCID patients treated with GT. The process started from the identifi cation of problems, moved to the defi nition of the assistance priorities as well as of the result indicators, allowing to perform the required interventions supported by scientifi c motivations. Conclusion: Planning of the nursing care is the method to guarantee the cures with respect to the different patients and their needs of personalization. The nursing plan helps to guarantee the optimal assistance results based on the literature and permits to reduce the unevenness of the nursing practice. However, promoting the patient and family involvement allows to consider clinical and emotional problems, linguistics and sociocultural differences and to reach the best grade of quality and safety during the care supplied from the multi-disciplinary team. Our strategy is now being applied to gene therapy for WiskottAldrich Syndrome and Metachromatic Leukodistrophy, adapting the approach to specifi c disease-and study-related issues.
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Comparison between the hospital nutritional goal and the result from a pilot study at a haematology ward
Introduction: Patients, treated with chemotherapy conditioning before bonemarrow transplantation has an increased risk for malnutrition due to severe side effects. Especially nausea /vomiting, diarrhoea/constipation, mucositis and loss of appetite effects nutritional status negatively. Low calorie intake leads to weight loss and hereby prolonged recovery. The Akademiska University Hospitals (AUH) goal for nutrition is 75 % of energy needed for 70 % of the patients admitted. AUH Nutritionday take place once a year to fi nd out the nutritional status among hospitalised patients at one-day audit. Objective: The objective was to evaluate if the result from a pilot study from 2009 about expanded information and support from hospital staff to patients at the haematology ward about nutrition fulfi lled AUHs goal for nutrition at one day audit in 2009. Material and method: Twenty patients, > 18 years, treated with chemotherapy conditioning before bonemarrow transplantation were asked to fi ll out a questionnaire about daily calorie intake. Patient's height, weight and body mass index (BMI) was calculated. Calories needed and calorie intake was measured. The result from one nutritional day audit at AUH was registered and compared. Result: Seventy-nine percent of the patients from the pilot-study measured at the ninth day after admittance at the haematology ward reached the AUH goal at one day audit for nutrition. Conclusion: It is a great challenge for hospital staff to maintain nutritional status in this group of patients. Nutritional problem has a great infl uence on the wellbeing and recovery. It is important to compere the results of one-day audit with results from the ward because caregivers need to be involved in nutritional treatment to benefi t patient's nutritional outcome. Expanded information and support from hospital staff about nutritional issues may lead to a greater awareness among patients about the importance of maintaining calorie intake.
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Practitioner nurse "fi rst announce" consultation before allogeneic bone marrow transplantation: results of a patients' survey on quality and information K. Tabani, P. Rodriguez-Otero, V. Nocton, M. Robin, A. Petropoulou, R. Peffault de Latour, G. Socié Hôpital Saint Louis (Paris, FR) Aim: This prospective, descriptive study was conducted to assess the level of satisfaction of patients undergoing practitioner nurse "fi rst announce" consultation before allogeneic bone marrow transplantation in a academic setting. Patients and methods: Between March 2009-March 2010, 33 consecutive patients for whom allogeneic bone marrow transplantation was planned underwent a practitioner "fi rst announce" consultation. Afterwards patients were asked to fi ll out a survey which consisted on 13 specifi c items evaluating the quality and the information received during such consultation. Results: All patients fulfi lled the survey. Delay from physician consultation to nurse consultation was found adequate in 87% of cases. 52% of patients were accompanied by a familiar or a friend; 33% did not want to be accompanied. 93% and 97% of patients found appropriate both reception and environment of the consultation, respectively. Overall, most patients found that information provided by the nurse enabled them to better understand allogeneic bone marrow transplantation procedure in addition to physician's information. 79%, 49%, 58% and 40% found that nurse answers regarding treatment effect on familiars, couple, children and professional activity satisfactory. 60%, 54%, 73% and 70% also found adapted the information about personal organization, social domain, body image and self-esteem, respectively. Prior concern, needs of information and organization skills improved signifi cantly after nurse "fi rst announce" consultation in more than 90% of patients. Conclusions: Results of this survey suggest that patients undergoing allogeneic bone marrow transplantation fi nd nurse "fi rst announce" consultation extremely helpful and complementary to physician's information.
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Welcome disposal in HSCT paediatric unit C. Sozeau, C. Palasse, F. Hemery, J. Kanold, F. Deméocq CHU Clermont-Ferrand (Clermont-Ferrand, FR) In our center we take care 15 childrens by years for allogenic HSCT. 30% were initially treated in another center and went for HSCT. To respond family queries and JACIE (Joint Accreditation Commitee of International society for cellular therapy and European bone marrow transplantation) requests we developed an Welcome Disposal. This Disposal consisted of: 1. Pre-transplant consultation performed by phycician with presence of the referent nurse. 2. Consultation nurse 3. Traceability of information given (medical mail, document of education) integrated into the fi le of the child It is important to underline the benefi t for the child and his family: 1. Personalized and adapted assistance 2. Clear and precise information 3. Hospitalization' dedramatisation (visit of the sector grafts, presentation of the medical team and multi-fi eld, explanations of the care) 4. Referent nurse (of accompaniment) is a person resource: a key position. 5. To anticipate the specifi c needs of the child, to adapt them to the recommendations of hygiene, and also to better appreciate the child on the family socio level. The referent nurse developed competences around the concepts of accompaniment, empathy, clinical nurse, education and care.
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The traceability of this Welkome Disposal supports the transmission of information with the teams of the hospitals of reference.
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Allogeneic BMT patient education and body temperature monitoring after hospital transplantation stage L. Tardieu, C. Granet, K. Aubert, E. Malissein, J. Guillout, E. Robin, S. Girault, P. Turlure, D. Bordessoule CHU Dupuytren (Limoges, FR) Introduction: Nursing consultation was introduced in hematology service, to educate transplant patients after leaving hospital. This approach has been reinforced by a specifi c action: monitoring body temperature (BT) after allogeneic bone marrow transplantation (BMT). Indeed, BT monitoring is an important clinical data for BMT follow-up and it must be done at home with rigorous method to identify and prevent infectious complication. A educational booklet with explications and a free electronic thermometer (ET) are done to each patient. Description: A committee composed of graduate nurses, executives, doctors, BMT staff and "Réseau Hématolim" have prepared a specifi c document to explain ways to take BT. A therapeutic educational consultation is done with a graduate nurse after leaving protected transplant area, she gives personally ET and advice notice. Explanatory document content:
TC information: it can variate along the day (low in the morning compared to the evening). TC should be taken with precise rules: put ET against cheek, along the gums or under the tongue, close lips around ET and breathe quietly through the nose without biting ET. A number will be appeared on ET after the beep, add 0.4°C before noting BT on monitoring book. Remove partial denture if necessary. Do not smoke during the last ten minutes. Do not drink hot or cold twenty minutes before taking BT. The patient will not take his BT orally in the case of mouth lesion, canker sore, mucositis or herpes. By axillary method, the armpit of patient must be dried, ET is placed in the hollow of his armpit and the arm must be folded against the thorax. Add 0.9°C before noting BT on monitoring book. Anal way is formally inadvisable. High temperature, natural defense mechanism against infection and ET disinfection informations. Finally, at the end of the consultation, the graduate nurse must check the patient's ability to follow the recommended procedure. Conclusion: BT medical supervision is important during BMT follow-up. This data allows to detect quickly infectious problem which could become serious if it's not rapidly noticed, despite the diffi culties of interpretation related to corticosteroids treatments. It's important to know and respect rules of use. The specifi c advice notice represents an essential document for the patient. ET is personal; it must not be loaned or exchanged. Patients appreciate TE gift and we have always acknowledgements.
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Development of a neutropenic sepsis alert card for chemotherapy patients S. Adams Bristol Haematology and Oncology Centre (Bristol, UK)
Background: Recent national reports (NCEPOD 2008 , NCAG 2009 ) have highlighted the need for improved patient information regarding neutropenia and associated sepsis following chemotherapy treatment. The reports found that patients often underestimated, or were unaware of the importance of reporting fevers and other symptoms of infection and sepsis promptly and often delayed contacting their treatment centre for advice. Delays also occurred when patients did not know
who to contact for advice,especially out of hours, and when they did seek advice it was not always from their specialist treatment centre. Both reports recommended the use of chemotherapy alert cards with information about side effects and whom to contact if problems arise.This prompted an investigation into the information given to patients receiving chemotherapy at the Bristol Haematology and Oncology Centre (BHOC). Aim: To design and introduce a neutropenic sepsis alert card for patients receiving chemotherapy at BHOC. Method: A review of alert cards currently in use in other centres in the UK found a wide variation in designs and information included on the cards. A draft card was designed incorporating information taken from the trust's website and patient information leafl et 'What is Chemotherapy?'. Draft copies of the card were distributed to nursing and medical staff within the centre to obtain feedback on the design and information included on the card, before a fi nal version was printed. Result: The production of a wallet sized neutropenic sepsis alert card for use by patients receiving chemotherapy at BHOC. The card provides a handy reference, listing potential signs of infection, and clear instructions to report any symptoms immediately to their treatment centre for advice and potential assessment, along with contact numbers, including out of hours numbers.The card will also act as a prompt to medical staff assessing the patient, alerting them to the fact that the patient is receiving chemotherapy, the high risk of neutropenic sepsis, and referring them to the trust's neutropenic sepsis policy for advice and guidance on treatment. Conclusion: The alert cards complement existing information given to patients.The overall aim is to reduce the number of patients who delay contacting the BHOC for advice,by emphasising the need to seek help early.By seeking advice early, overall patient outcome should improve. The introduction and effectiveness of the cards will be audited through patient questionnaires.
Protective care P1349 GITMO survey: dietary management in patients undergoing HSCT
A. Trunfi o, C. Brignoli, L. Cassia, R. Invernizzi,
L. Galgano on behalf of GITMO
Radiation therapy and chemotherapy protocols for Haematopoietic Stem Cell Transplantation (HSCT) conditioning regimens exert signifi cant toxicity against tissues characterized by rapid cell turnover such as the gastrointestinal mucosa. Currently the choice of the appropriate diet before and/or after transplantation is still matter of debate, is not supported by guidelines, and is most often suggested by personal experience. Notably, it is still commonly held that inadequate food intake contributes signifi cantly to worsen the degree of mucositis, associated symptoms and risk of bleeding and infection. Between 2009-2010, a survey was conducted among GITMO HSCT centers to fi nd out the approach of different HSCT units on diet regimens in transplanted patients in relation to:
The procedures for preparing and serving meals The existence of internal/hospital recommendations, nutritional care planning and diet education for transplant patients The diet style during the conditioning regimen for HSCT and during the following phase of neutropenia
The indications for total parenteral nutrition and methods of weaning after fasting. A questionnaire was drawn up and sent to 88 Italian GITMO centers. 52 centers (59%) contributed to the survey. The collected data were analyzed though an ad hoc database. Results: In most GITMO Centers:
Meal preparation is done in equal proportion by a central hospital kitchen or from external services, while distribution is always supplied through a custom tray; All centers use internal recommendations on nutrition, and all patients receive information. Dietitians are called if required The diet provided during conditioning and post-transplant is standardized as for all patients with neutropenia (low microbial load and cooked foods); Total parenteral nutrition is generally personalized and is almost always provided for caloric supply in case of inadequate oral intake because of nausea or mucositis. Weaning after fasting is always planned and it always occurs gradually, following a specifi c diet.
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The incidence of pulmonary and bronchial infections in patients after haematopoietic stem cell transplantation performed in HEPA or non-HEPA fi ltered rooms -An observational study: fi rstyear experience
Introduction: High effi ciency particulate air (HEPA) fi ltered rooms are generally recommended in hematopoietic stem cell transplantations (SCT), especially for those allogeneic. In some transplant centers, however, the HEPA fi ltration is not available. Literature data comparing the incidence of pulmonary and bronchial infections in HEPA or non-HEPA fi ltered rooms are rare. The East Forum EBMT-NG has been conducting an observational study since 1/2010 to get more information about this issue. Assumption: SCT may be safely performed even in non-HEPA fi ltered rooms. Objectives: To analyze the incidence of pulmonary and bronchial infections in respect to HEPA or non-HEPA fi ltration available in the transplantation rooms. Methods and patients: Observational, prospective, multicenter study focused to the East European BMT centers. Patients undergoing the autologous or allogeneic SCT will be enrolled into this observation consecutively and every transplanted patient in a BMT center will be registered. Defi nitions: Pulmonary or bronchial infection=clinical sings of pulmonary or bronchial affection (i.e. cough, dyspnoe) or radiological changes (RTG, CT) together with elevated body temperature and/or CRP. Monitoring: Specifi c pre-printed monitoring card is designed for the data recording. The observational period starts on a patient´s admission and fi nishes on day +100 post-transplant. The fi rst year results: 93 patients have been registered into the study in 1-10/2010 so far, 3 centers are active in cooperation and 2 more consider the participation, 10 centers have not responded the invitation to the project yet. Discussion: Much larger numbers of patients are needed before any fair results can be made. This study is conducted and focused to East European BMT centers in an effort to help support mutual regional cooperation, which will not be an easy work, as only a minority of the centers have responded and started cooperation. BMT centres without HEPA fi ltered rooms are welcome.
•
P1351 Holding hands in infection control M. Lourenço, J. Pedrosa Hospital Santa Maria (Lisbon, PT)
MARANTIDES and others (2003) argued that people with compromised immune systems, such as hemato-oncology patients, were highly susceptible to fatal infections. In this context and once hand hygiene is "one of the most simple and effective ways in reducing infection in what concerns health care" (DGS, normative Circular No. 13, 2010), we considered of great relevance to study this issue. The main aims outlined for this study were, on one hand to evaluate the technique, the circumstances and the practice of hand washing in the service where we provide care and on the other hand, to submit to the health team, solutions to problems arising during this period. The study was conducted in a simple descriptive and exploratory way and it was used as a quantitative analysis. A non probabilistic by convenience sample was used, comprised of seventeen nurses who work in direct care, eleven operational assistants, four doctors and two other health professionals who were in the unit during the study period (August 1st 2010 to 1st September 2010). The data were collected through direct observation and introduced in an observation grid. Within the range of procedures observed, it was found that nurses and doctors, are the groups who mostly wash their hands showing higher mean relative frequencies relating to hand hygiene after the procedures (70.3% and 83.3% respectively -Classifi cation of "Good" in the practice). However, before the procedures there was a lower practice (30.7% of nurses -accession "Very unsatisfactory", 55.6% of doctors -accession "Satisfactory."). It is essential to take into account that the doctors are a sample of 11,8% of the professionals observed, while the nurses represent 50.0%. Beyond that, the number of observations was different for the different professional classes; therefore no conclusions were drawn from the comparative forum. The class of operational assistants (32.4% of the sample) has a "Very unsatisfactory" (3.8%) practice before the procedures and "Unsatisfactory" (47.7%) after them. The other health professionals have a practice of 0.0% ("Very Unsatisfactory"), before and after the observed procedures. Therefore, based on the results, we get to the conclusion that there is an urgent need to carry out specifi c strategies, in order to promote a greater awareness of the importance of using correct technique, concerning hand hygiene in hospital infection control, with the various professional groups.
P1352 Longitudinal assessment of viral infections in haematopoietic stem cell transplant recipients and development of a standard operation procedure for the prevention of viral infections at an outpatient clinic C. Höhener, S. Degen Kellerhals, M. Kirsch University Hospital Basel (Basel, CH)
Introduction: Increasing attention is focussed on the occurrence of infections in the long-term follow-up of autologous and allogeneic haematopoietic stem cell transplantation (HSCT). Multidisciplinary teams are urged to develop tools to prevent infections and their transmission amongst patients attending outpatient clinics. Moreover, the early identifi cation and treatment of affected patients is important. In teams questions are raised how to support patient safety with regards to prevention of infections at outpatient clinics. Aim: In the outpatient clinic for autologous and allogeneic HSCT recipients of the University Hospital Basel incidence and causative pathogen of viral infections were recorded two years. Additionally, in a joint project with the Department of Hygiene and Infection Control a standard operation procedure (SOP) involving various measures for isolation care were developed and evaluated.
Method: All patients who showed or reported signs of respiratory infections received a nasopharyngeal swab and a bloodtest. SOP were developed by a multidisciplinary team consisting of haematologists, infectiologists and nurses. Results: 175 patients were identifi ed having a viral infection between January 2009-November 2010. Infections with RSV (n=36) Infl uenza A (n=12), B (n=8) and Parainfl uenza virus (n=29) were the most frequent. Depending on the identifi ed pathogen specifi c isolation procedures were tailored. To avoid transmission of infections to other immunosuppressed patients, all patients with signs of infections (fever, cold, coughing) were urged to enter the outpatients clinics wearing a face mask. Examinations took place in separate rooms with special air fi lters. In case of aggressive pathogens, patients were referred to a different ward. All staff members had to wear face mask, gloves, gowns and in certain cases even goggles. Routine nasopharyngeal swabs were repeated depending on the recommendation of the Department for Hygiene and Infection Control. Conclusion: Through rapid identifi cation of causative viruses, optimal treatment could be initiated and the treatment duration was less. Thanks to rapid processing, medical treatment decisions based on the result of the swab can usually be made already on the same day. These measures helped to optimize care of infected immunosuppressed patients. The guidelines ensured protection and avoided the spreading of infections. In future, we will continue to carry out these precautionary measures. Oral mucositis (OM) is a common complication after autologous and allogeneic stem cell transplantation (SCT) in hematologic patients (pts). OM is responsible for an important morbidity causing pain, resulting in diffi culties to maintain hydratation and oral intakes with risk of malnutrition. Mucositis plays also a role in local and systemic infections due to disruption of mucosal barrier. Caphosol is a calcium phosphate supersaturated mouth rinse proposed as a new prophylactic agent to prevent OM. We conducted a prospective study to evaluate feasibility and effi cacy of this innovative treatment among transplanted pts. Caphosol was administered from the beginning of conditioning until the end of neutropenia (neutrophil count > 500 per mm 3 ). Four rinses per day were recommended. In case of OM rinses were increased up to ten times a day. The main objective was to assess OM incidence and severity according to OMS grading. Secondary objectives were to evaluate pts satisfaction, taste, compliance and feasibility (scale from 1 to 4 for each parameter). Twenty eight pts were included between January and July 2009, 20 after autologous SCT (11 lymphomas and 9 myelomas) and 8 after allogeneic SCT (5 acute lymphoblastic leukemias, 1 lymphoblastic lymphoma [LL], 1 acute myeloid leukemia, 1 biphenotypic leukemia). As conditioning regimen patients received BEAM (10 pts with lymphoma), cyclophosphamide and total body irradiation (12 gy) (Cy-TBI) (7 pts with leukemia, 1 LL and 1 Hodgkin lymphoma) and melphalan (9 pts with myeloma). Eight pts (29%) never experienced OM (3 after BEAM, 4 after melphalan and 1 after Cy-TBI). Grade 1 and 2 OM was noted in 16 pts (57%). Finally, 4 pts (14%) suffered from grade 3-4 OM (after Cy-TBI). Nighty nine per cent of pts were "satisfi ed" or "very satisfi ed". Taste was well supported in 60% of pts, only 1 patient stopped treatment because of aversion of the taste. Nighty nine per cent of pts were compliant. In 95% of cases nurses were "satisfi ed" or "very satisfi ed" regarding treatment feasibility. Further results focusing on opioid analgesia requirement and nutrition parameters in comparison with matched patients will be presented at congress.
P1353
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High-dose chemotherapy and mucositis: nurses' and patients' points of view in an evaluation of supersaturated calcium phosphate oral rinse E. Recchia, L. Chouchana, C. Benitah, E. Geneste, N. Pippo, C. Bompoint, R. Adaeva, S. Lapusan, M.T. Rubio, A.C. Joly, B. Rio Saint Antoine Hospital (Paris, FR) Mucositis, potential acute adverse of conditioning chemotherapy, remains a concern of care teams because of extremes pains, secondary infections and undernutrition risks. Mucositis incidence and intensity seem to be reduced by the use of supersaturated calcium phosphate oral rinse (SCPOR). Our objective was to estimate potential benefi t of this prophylaxis by introducing SCPOR at day 1 of conditioning chemotherapy. Method: A multidisciplinary team (nurses, pharmacists, physicians) realized a study with 23 patients of 2 haematology departments from January to October 2010. An evaluation form was fi lled by each nurse (3 times a day), with realized number of SCPOR, mucositis stage, pain (estimated by pain scale and analgesics prescriptions), patients and nursing satisfactions. Results and discussion: Patients point of view: 83% appreciate the taste, 56% were satisfi ed by the SCPOR. Their main remarks were: fresh and clean mouth sensation, fewer nauseas and oral rinses possible in spite of the mucositis. The satisfaction decreases with approximately 70% of opinions changes when mucositis appears. Patients realized the number of recommended SCPOR in 50% of the cases. Patients received an antifungal additional treatment. Nurses point of view: observance was satisfactory in 93%, SCPOR is practical with the single doses. It was diffi cult to obtain information of equal quality throughout the care. A daily evaluation with always the same nurse would have been more sensible. Conclusion: The evaluation limit (no comparative arm) led to a subjective study according to collected data from patients and nurses. In practice, nurses notice that with nowadays treatments, mucositis are less disabling, with a reduced duration, but the pharyngeal localization remains present and painful. The only impact of SCPOR is diffi cult to bring to light, it is infl uenced by conditioning chemotherapy intensity, administration modalities and associations with others local and general therapeutics. This study allowed us to highlight some points which we would be interested to investigate furthermore as fewer nauseas incidence and how to associate antifungal in the aim of better effi ciency and patient comfort.
Psycho-social issues
P1355
Body image dissatisfaction in a young female during haematopoietic stem cell transplantation: a nursing experience Y.-C. Huang, P.-J. Yu, C.-F. Chang National Taiwan University (Taipei, TW) Background: In addition to alopecia or hair loss, skin pigmentation caused by high dose chemotherapy during the hematopoietic stem cell transplantation (HSCT), skin rash caused by engraftment or Graft-versus-host disease (GVHD) and body swelling of steroid treatment may change a person's body image. Owing to the use of steroid, there are many different poorly healing wounds disturbing patients (bone marrow biopsy S427 wound, Central Venous Catheter (CVC) removed wound). Patients may be concerned about whether the wounds will lead ugly scars on their skin or not. In the process hospitalization for transplant, some patients become very anxious when they see themselves being disfi gured day by day because of those scars. It's diffi cult to accept this, making this even more diffi cult to accept any treatment. Objective: To help the patient accept and face the changes of body image during HSCT. Method: A female case with graft failure, and had second transplant was chosen. Owing to repeated febrile neutropenia, she received low dose steroid treatment, which cause her wound healed slowly. The special nursing measures were done from Nov. 13 to 19 2010 in order to help her accept and face the changes of body image. The nursing intervention was to take daily photos recording the CVC wound on her neck, and to encourage her to observe the wound change together. Result: We found that the patient was unable to accept her neck full of wound and scars, and she had never known what her neck looked like. After observing the changes of the wound everyday by the photos, the patient realized that the wound wasn't as horrible as she thought. She felt more at ease when looking at the wound photos, and she also realized that it will take some time for wound healing after HSCT. Conclusion: Nurses and doctors would bluntly tell patients what's happened to their body during transplant, but never offer the patients options to lessen the possible problems. The patients may feel upset due to the emergence of more and more wounds or scars on their body which are new and not caused by them. The way to let the patients accept their own body image is to make them understand why the changes are done, and to help them to further accept the changes. In addition, letting the patients realize that all the changes are just temporary. The wounds and scars are dynamic, not permanent. We must remind patients that wounds and scars can sometimes heal, and the body can recover to its original look one day.
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Limits to responsibility in care and aftercare on a paediatric stem cell transplantation unit A.G.M. Neuman-van Eijk, C.L. Vermont Leiden University Medical Center (Leiden, NL) Introduction: Care workers in our pediatric unit for stem cell transplantation are confronted with increasing psychosocial problems of our patients and their families and arising dilemmas in complicated treatments. Years of experience let us know that the decision of treatment mostly is based on medical grounds. Nowadays other than medical issues play a more prominent role in and after stem cell transplantation in children. In our unit we have made a procedure to induce a 'proof hospitalization' when problems reasonably are expected, to make sure a stem cell will be feasible. Structural appointments will be made with parents/attendants and child to make sure that hospitalization will be successful. Accompaniment during this stay mostly works out well; problems in between on psychosocial levels are being discussed, evaluated and policy is adjusted when necessary. When a child is dismissed from the hospital, necessary homecare is being initiated as well as possible. It is not always easy to stipulate to what extent and for how long the treating team from hospital is responsible for the (coordination of) care. Moreover many aspects like geographic aspects, insurance aspects, fi nancial aspects, etcetera can have their infl uence. The goal of this presentation is to make clear to colleagues, by means of casuistry, examples of the infl uence of other than medical problems that can occur in a stem cell transplantation route and its aftercare. Also examples of how to monitor and to share responsibility in a homecare route after stem cell transplantation in cooperation with home care providers will be presented.
Sexuality
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Sexuality and graft-versus-host disease one year after allegeniec haematopoietic cell transplantation K. Thygesen, M. Schmidt, M. Jarden, I. Schiødt Rigshospitalet (Copenhagen, DK) Background: Allogeniec haematopoietic cell transplantation (ALLO-HCT) involves severe immune-related complications, in particular Graft-versus-host-Disease (GvHD), which is the primary cause of morbidity, mortality and decreased quality of life after ALLO-HCT including sexual dysfunction. GvHD and its treatment with high dose corticosteroids may cause changes of the physical appearance of the patient, to such an extent that the sexuality and body image of the patient is seriously affected. Sexual dysfunction has been defi ned as one of the most common long-term issues following HSCT. It is directly related to genital GvHD and is a very frequent, yet unexplored, problem in longterm survivors after ALLO-HCT. Object: To identify which changes of sexuality the patients experience one year after ALLO-HCT, and relate this to body image, depression/anxiety, and GvHD. Materials and methods: All patients are recruited from the BMTunit, Rigshospitalet, Copenhagen, Denmark. The study period is from 20th of September 2010-October 2012. The study is a prospective follow up study with baseline evaluations at 2-3 weeks before ALLO-HCT and follow-up one year after ALLO-HCT. Three quantitative and validated questionnaires are used, and correlated to a GvHD registration form: "SFQ: Sexual Functioning Questionnaire", "Body Image Scale" and "Hospital Anxiety and Depression Scale". Clinical implications: With this study we hope to bring focus on the alterations of sexuality, seen in ALLO-HCT patients, particularly in patients with GvHD. Hopefully this may lead to preventive interventions that may improve quality of life in ALLO-HCT patients.
Standards of care
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The role of BMT nurses in early identifi cation and management of sepsis L. Froymovich, M. Furer, N. Katzman, V. Latergaus Rambam Medical Center (Haifa, IL) Objectives: Patients undergoing stem cell transplantation (SCT) are at risk of developing infection-related sepsis. Timely and effi cient involvement of nurses is crucial for intensive medical management of such patients. Sepsis treatment provided by medical institutions has signifi cantly improved over the past decade; however, sepsis-associated mortality remains unacceptably high, ranging between 29%-50%. Risk of death rises if appropriate therapy is delayed: every hour of delay increases mortality by 7.6%. While the average time of sepsis detection and start of management is 6 hours, the high mortality rate is partly related to prolonged time between the start of sepsis and treatment initiation. Neutropenic patients are at even higher risk of irreversible sepsis due to immunosuppression. Prompt diagnosis and treatment are critical for these patients, who require early goal directed therapy. Nurses involved in the care of SCT patients are the fi rst to identify and treat sepsis due to their tight contact with patients. The study is aimed to minimize the time between the start of sepsis and treatment and to provide rapid identifi cation of causative organisms; appropriate antimicrobial therapy; adequate hemodynamic support; glycogenic control; effective supportive therapies and, most important, patient management by highly qualifi ed nursing staff. Methods: For the last 5 months we have applied a checklist identifying fi rst signs of sepsis. The checklist was developed by the departmental senior staff and adopted by nurses and physicians. Each patient developing 2 signs indicative of possible sepsis is being monitored every 15 minutes for vital signs and if sepsis is diagnosed, a series of actions are taken aimed to provide hemodynamic and antimicrobial support. Results: Upon implementation of the checklist, nurses' alertness to sepsis has increased, the state is promptly identifi ed and physicians are earlier informed, leading to decrease in mortality. At our department, an average time for sepsis detection and treatment initiation has decreased to 2 hours. Conclusion: The developed checklist of sepsis identifi cation has been found to be a simple and clear instrument. It will be subject to refi nement after a period of evaluation. It also provides a "map' of pitfalls in sepsis treatment. Further investigation of options to reduce time preceding sepsis identifi cation in SCT patients is required in order to decrease sepsis-related mortality in this population.
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A new nursing intervention in NIC taxonomy: infusion of haematopoietic stem cells
ES); (2)Distrito Atención Primaria (Sevilla, ES)
Introduction: The Nursing Interventions Classifi cation (NIC) is a comprehensive standardized language to describe the treatments that nurses perform. The Classifi cations are useful in planning and documenting care, in communicating the essence of nursing to others, and in the implementation of large databases for research on the effectiveness of nursing care. However, the Infusion of Haemopoietic Stem Cells cannot be adequately registered and included within care plans, even though this procedure is performed by the nursing staff and is a daily practice in Haemopoietic Transplant Units. Our project consisted in the development of a new nursing intervention under the label: infusion of haemopoietic stem cells (IHSC), to be included within the NIC -the classifi cation facilitated by the Center for Nursing Classifi cation and clinical effectiveness in the College of Nursing at the University of Iowa. Objetives: 1) To defi ne and describe the activities that nurses perform during the IHSC; 2) To facilitate and allow the use of nursing methodology in our provision of nursing care; 3) To register and include the IHSC within standard care plan for hematopoietic stem cell transplant recipients. Methods: 1) Bibliographic systematic review to identify the best evidence about IHSC; 2) Drawing up the manuscript containing: the current status and particular aspects of IHSC; why a nursing intervention; importance of including this intervention into nursing methodology and fi nally, the list of activities that describe what a nurse does to carry out the intervention. Results: This work represents the development of a new intervention labeled as IHSC, composed of 30 bibliographically documented activities that supports the intervention. In August, 2008 we sent and submitted the proposal to the university of Iowa for clinical review, suggesting to be included as an intervention of Level 2 Domain. Physiologic: Complex and Class N: control of "tissular perfusion". In September, 2010 we received the acceptance notice from Iowa: it had been accepted for inclusion in the next 6th edition of NIC. Conclusions: The inclusion in NIC of this new intervention will help to standardize the nomenclature about nursing care in the transplant settings, providing a language to communicate among nurses, facilitating clinical documentation, effectiveness research and productivity measurement, and also, it could improve the quality of care by reducing the variability in this nursing practice setting.
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Nursing involvement in developing quality goals enlarges the scope of their work L. Guardia , Y. Torralba, A. Mantecón, N. Borràs, C. Moreno, C. Barrera, N. Ortiz, M. Valverde Hospital Clínic BCN (Barcelona, ES) Background: Since March 2008 in our Institution the Joint Accreditation Committee -ISCT and EBMT (JACIE) accreditation offi cially states that the Stem Cell Transplantation (SCT) Programme fulfi lls JACIE requirements; JACIE Standards accomplishment guarantees quality services to patients undergoing Autologous or Allogenic SCT. Standards of care are planned by the Clinical Quality Committee. In 2010 it was proposed to improve the Nursing Discharges Notes (NDN) structure and content in order to ensure continuity of care, taking into account that Hemato-oncology patients need complex treatment and care provided at different levels of the health system. Once created the Standard Operating Procedure (SOP) to produce NDN template, it was implemented and assessed by analyzing two Quality Indicators (QIs). The expected outcome was established beyond 80% the fi rst year of implementation. Aim: To assess adherence to "The Nursing Discharges Notes Elaboration" SOP and NDN concordance to medical records. Method: The Clinical Quality Committee proposed to create a nursing team with nurses from SCT, Outpacient Clinic, Hematooncology and Home Care Units. They were responsible for the NDN-SOP contents writing, the implemention training and also the outcome evaluation process. In order to evaluate adherence to the SOP and concordance with medical records a check-list was developed and validated by the criterion unit methodology. Results: After the new SOP was introduced, two QIs were analysed from April to September. 108 NDN were produced in SCT Unit, 21 of which were reviewed and 17 of these belonged to patients discharged from the patients undergoing Autologous or Allogenic SCT. Adhesion to the SOP was 89.10% on the second quarter of 2010 and 94.01% on the third. Regarding NDN concordance to medical records 86.70% and 87.01% were achieved on the second and third quarter respectively. Conclusion: The Nursing Discharges Notes Elaboration SOP is well implemented by staff nurses since both QIs are optimalwith an expected outcome beyond 80%. From our understanding, the success of this goal has been possible because the nurses who have led the project use the SOP in their every day work and they have good knowledge of the subject. Next year propposal will be to explore the usefulness and effectiveness of the information provided and the impact of the NDN on Hemato-oncology patient continuous care.
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Can platelets be unnecessary? S. Vieira, D. Monroe, M. Madziwanzira, A. Donkin, M. Librojo, H. Chipudhla, N. Amin, L. Porin, L. Chavez, M. Palomar, C. Bernardez The Trustee of London Clinic (London, UK) Introduction: Blood transfusion continues to be an essential part of modern nursing practise but it is not without risk. During the last decade there has been an increased interest in the national level of practice across the United Kingdom (UK) and Europe and involving the hazards of transfusion of blood components. Therefore avoiding unnecessary transfusion is accepted as one way of reducing the risk which is associated with blood transfusion. In our stem cell transplant unit we have audited platelet transfusion (PT) frequency and requirement. Method: The audit was carried out prospectively. A 'log in' book was kept on the Unit for recording the platelet transfusion orders. The data was validated with cross check retrospective inpatient records on a monthly basis. The audit was carried out over a 6 month period, form May 2010 until the end of October 2010. Our hospital policy for uncomplicated-inpatients, is to keep the platelet count ≥ 10 or if complicated the aim is to keep the count at ≥ 20. We aim to keep platelet ≥50 if the patient is receiving anticoagulant or bleeding for various reasons. Result: In the six months period there were a total of 105 platelet transfusion episodes. 10% of these were routine transfusions i.e a platelet count of ≤ 10 X10 9 /L and 26% of transfusions were given because of bleeding episodes. However, because of an exceptional patient requirement where a patient failed to increment following platelet transfusion, 10% of platelet transfusions were given when the platelet count was higher than 31 x 10 9 /L. Overall 36% of the platelet transfusions were given when the platelet count was ≥31 x10 9 /L. Conclusion: Our organisation recognises the importance of risk associated unnecessary blood component transfusion. In the six months period, a total of 105 platelet transfusions were carried out and only 36.5% of these were complainant with the hospital policy. 9.5% of transfusions were given when the platelet count was ≥ 31 x10 9 /L. This was mainly due to an exceptional patient requirement who failed to increment following transfusion and this had the effect of changing the platelet trend on the Unit. 26% of PTs were given due to bleeding episodes and 19% were given as per hospital policy i.e. anticoagulant reversals. It is suggested that further studies are performed in order to monitor compliance with hospital policy, maybe at a time when the trend is not skewed by a single patient unusual requirement. Methods: Hand washing is the cornerstone of nursing care in our HSCT unit. Masks, gowns and gloves are not used before entering the patient (pt) room unless otherwise indicated (specifi c precautions). HSCT candidates are admitted for transplant in the main HSCT unit (ward I) and screened for RSV before admission. A second unit (ward II) is available for autologous transplants and admission of HSCT outpatients with complications. Respiratory symptoms were surveyed twice a week and nasal washes (NW) were taken if symptoms. RV diagnosis was made by DFA. RV infection was defi ned as hospital-acquired if the interval between admission and the beginning of symptoms was longer than 5 days. Results: During this period, 92 HSCT recipients had 100 episodes of RV infection. RSV was more frequently diagnosed (53 cases), followed by parainfl uenza (28 cases) and infl uenza A (17 cases). Median hospitalization time was 24 (2-131) days. In 46 episodes with more than 2 NW samples, the median duration of RV excretion was 6 (2 to 98) days. In 72 episodes, RV infections were diagnosed in the outpatient setting. In the remaining 28, RV infections were acquired during hospital stay and were characterized as hospital-transmitted in 23 of the 28 episodes (82.1%). The median time between admission and the beginning of respiratory symptoms was 24 (15-131) days. Hospitaltransmission was similar in both HSCT wards and signifi cantly
Conclusions: The control of RV transmission is complex. Other protective barriers in addition to hand washing and educational programs may be necessary to decrease nosocomial transmission of RV in our HSCT unit.
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The need for standardized feeding protocols in allogenenic transplant patients E. Ripley, K. Montanheiro University College London Hospitals (London, UK) Background: Currently at UCLH there are no standard feeding protocols in place for allogenenic transplant (AT) patients. This causes confusion at a ward level among doctors and nurses with what is the preferred feeding route. Therefore leading to an inconstancy in feeding patients varying from no artifi cial nutrition support, nasogastric feeding (NG), nasojejunal feeding (NJ) or intravenous nutrition (IVN). Conditioning regimens used for AT have severe effects on the gastrointestinal tract. This suboptimal oral intake can last for 2-3 weeks after transplantation (Horsley et al, 2005) . In the absence of nutrition support, malnutrition can occur rapidly and this may continue even after recovery of the bone marrow (Raynard, 2003) . Enteral nutrition (EN) is the preferred route of nutrition support for a functioning gastrointestinal tract due to its role in reducing bacterial translocation, by maintaining immunologic and barrier functions of the gut (Sigalet et al, 2004; Hastings et al, 2006) . This is in contrast to IVN, where there is mucosal atrophy and a reduction in luminal mucous gel, thereby increasing permeability of the small intestine (Langdana, 2001; Mattsson et al, 2006) . Objective: To implement an evidence based feeding protocol for AT patients at UCLH. Methods: An extensive literature review was carried out to identify preferred methods of feeding. This literature review included correspondence with other transplant units across the UK and information was obtained on their practices. From the literature review a protocol was developed which is intended to be implemented throughout the trust. Following this implementation an audit will be carried out to assess compliance, improvement in patient outcomes and to identify changes which Lauri et al (1997) on the basis of the needs identifi ed by Yura and Walsh. The validity of the translation of the Questionnaire was assessed by an English language expert. Reliability of the scale was evaluated with Cronbach's α (0.9). Results: Descriptive statistics revealed the patients' most common needs occurred in the vital functions area (46.5%), the functional health states (34.7%), reaction to functional health status (27.4%) and environmental needs (16.8%), respectively. The most important problems of patients related to vital functions were cold feet, feeling of weakness, cough, feeling cold generally. The patients were found to have problems related to nutrition, sleep / rest, elimination and pain within the functional health states category. Reaction to functional health status needs included items related to personality, belief system, religious sense, coping, and compliance. According to patients the most important need in the category of environmental needs was lack of information about state of health. Conclusion: The results of this study confi rmed that patients undergoing HSCT suffered from problems related to unmet needs. Regarding to these needs, specialized nursing interventions is necessary for these patients. This study provides nurses with concrete information in order to better understand patients' needs and try to meet their expectations, resulting in improved nursing care in HSCT units. Objectives: At the 2009 meeting of the GITMO nurses group, a wide heterogeneity has emerged among the participating centers regarding the indications to the collection of samples for microbiological studies. Therefore we planned a study aiming at defi ning practice guidelines as based on EBN/EBM criteria. Methods: The nurse responsible for infections within the GITMO group performed a search in the literature on the timing and methods of blood cultures and swabs for microbiological studies. The search was performed on the main medical databases, and three reference reports were selected as having top priority: "Taking blood cultures"-NHS, "Clinical Practice Guideline for the Diagnosis and Management of Intravascular CatheterRelated Infection: 2009 Update by the Infectious Diseases Society of America"-IDSA GUIDELINE, and "Principles and Procedures for Blood Cultures; Approved Guideline" -CLSI. Furthermore, we prepared a questionnaire concerning the methods and timing of the harvest of samples for microbiological studies after HSCT. The questionnaire was fi rst tested in a small group of centers, then sent on February 2010 to all adult and pediatric GITMO centers. Results: Out of 88 questionnaires, only 48 (54.5%) were correctly fi lled and returned. The analysis of the results show that most centers did not adhere to the existing reccomendations and that there was a wide heterogeneity among the centers regarding:
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the methods of performing blood cultures, such as the number of samples to be collected, whether samples were collected from a peripheral rather than a central venous access and the methods of skin disinfection before venipuncture; the timing of sample collection, both for blood and swab cultures; the general trend to perform routine microbiological studies at fi xed time points rather than based on clinical indications. Conclusion: Based on our study, it appears that all centers, including nurses and physicians as well, should be more thoroughly informed/educated on the existing practice guidelines. The eventual changes in clinical practice at each center will be evaluated by sending the questionnaire again by the end of 2011.
P1366
Patient care in children receiving haplo-identical stem cell transplantation R. Kampschulte, A. Klaus, U. Ulrich, D. Heiß, C. Seifert, T. Klingebiel, P. Bader Universty Hospital (Frankfurt, DE) The paediatric stem cell transplantation centre of the Goethe University Frankfurt transplants approximately 50 patients of every age annually. During the past decades tremendous efforts have been taken to improve haploidentical transplant procedures for patients lackinga HLA identical donor. We are performing around 20 haploidentical transplantations a year. Because of the high suppression of the immune system, special considerations are necessary for the clinical care of the children. All patients are treated in special hepar fi ltred rooms. They have to shower every morning with a special oil-conditioning shower soap to protect the skin. During this procedure the nurses look carefully at skin, oral mucosa and the central line. The laundry must be changed every day. It is washed with the use of special disinfection detergent at 60° C. Furthermore all patients receive special germ-reduced nutrition until day +100. Weekly there is an examination by taking blood samples, throat swabs, swabs of venous catheter and screenings of stool and urine for germs and viruses. Once or twice a week blood samples arre taken to control chimerism and regeneration of the immune system. Having reached 1000 Leucocytes for 3 days in a row the airlock-chamber is open and the children are taken for short distance walks. After regeneration and oral intake of all drugs patients are discharged around day +30. The patient is obligated to visit the SCT outpatient department weekly. Blood tests and frequent physical examinations by a doctor are conducted. Blood examinations, bone marrow aspiration and special diagnostics are performed on day +60, +100,+200. During the following fi ve years annual check-ups are necessary. Until day +100 restrictions are set regarding personal activities such as school attendance and access of puplic buildings. Surgical masks and germ reduced nutrition are obligatory during the fi rst 100 days. • results in recent years by following the way described above. Eight of 71 children died due to non relapse mortality (TRM) leading to a TRM rate of 11%. We hope to help more children by performing haploidentical transplantations in the future.
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The impact of infusing autologous haematopoietic progenitor stem cells via a standard volumetric pump on colony forming unit: granular macrocyte recovery post infusion R. Howard Auckland District Health Board (Auckland, NZ) Cryopreservation and thawing of Haemopoietic Progenitor Stem Cells (HPC) is associated with cell loss. We investigated whether the use of a volumetric pump for administration of the thawed autologous HPC`s would further induce cell loss and affect Colony Forming Unit -Granular Macrocyte (CFU-GM) recovery post infusion. The literature is not explicit in advocating the particular method to administer cryopreserved autologous HPC. Literature has supported the use of using a `Gemini` pump for infusion of HPC; but a broad review of available hospital based protocols would indicate that there is variance in practice worldwide in the actual delivery procedure undertaken to administer thawed cells at the bedside. The results of a retrospective analysis undertaken post a change in HPC administration practice at a Bone Marrow Transplant Centre in New Zealand will be presented. The analysis compares CFU-GM recovery in patients who received thawed cryopreseved HPC cells via a `syring push` method versus patients who received their HPC product administered via a standard volumetric pump device. The change in practice ensured that administration time per ml of HPC product would be consistent without the fl uctuations experienced in administration when the HPC product is manually `pushed` using a syringe technique. Increased CFU-GM recovery allows for prompt and endurable graft recovery, therefore shortening the period of neutropenia and limiting the neutropenia associated complications.
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Nursing management of peripheral insertion central catheter in a complicated paediatric patient: a case report C. Soliman, D. Previtali, F. Buzzi, F. Barzaghi, M.P. Cicalese, A. Assanelli, M.G. Roncarolo, R. Bacchetta, F. Ciceri, P. Brambilla San Raffaele Hospital (Milan, IT) Background: E.M., a girl aged 8 years, was admitted to our Unit. The patient was affected by an immunedysregulation, characterized by autoimmune manifestations and immunodefi ciency, due to CD25 defi ciency (Caudy 2006) . She presented a severe psoriasiform dermatitis with skin superinfection, multiple lymphadenopaties and alopecia universalis. She was hospitalized for antiviral therapy for CMV reactivation, multiple intravenous antibiotic therapy for severe pustulous lesions, dermatitis not responsive to immunosuppressive therapy and lymphadenopaties requiring diagnostic work up. In order to guarantee a better management of these complex clinical case, a peripheral insertion central catheter (PICC) was implanted by nurse. Aim: To set a stable and long-lasting central venous catheter (CVC), which allowed the preservation of peripheral veins, reducing multiple venous punctures and the administration of several pharmacologic or supportive infusions, as well as the peripheral blood sampling. The CVC nurses management was fi nalized to limit the existing infection and to avoid the spreading of additional infectious complications, potentially fatal, such as sepsis. Method: The nursing activities were performed according to the international guidelines of preventing CVC infections translated S432 into working procedures on PICC management concerning placement, dressing, drug infusion, blood drawing, complications administration and removal. During daily shift, nurses checked the PICC (implanted point, surrounding skin area and infusion lines) and fi lled the nursing records. Results: The patient did not present any infection related to PICC, which was well tolerated and was maintained even after discharge. The use of PICC reduced the parents concern related to previous negative experiences with other kinds of CVC, moreover, it avoided the risks related to sedation. Main problems in fi xing the PICC were skin scaling and fl uid loss, which required changing the dressing frequently. Conclusion: The use of procedures allowed to uniform the nurses activity and to identify common, objective and reproducible parameters to evaluate the clinical situation and to guarantee a safe and high quality nursing care. The collaboration with parents, brought a better care results, gained through some fundamental principles of the health education. The management of complex pediatric patients requires a specifi c nursing competence that should be necessarily acquired by adequate training and practice.
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Development of a standardized nursing care plan and procedure to manage oral mucositis in patients undergoing haematopoietic stem cell transplantation J. Kristiansen, J. Koksvik, A. Brager Oslo University Hospital (Oslo, NO) Introduction: Oral mucositis (OM) is the most common and signifi cant early complication of hematopoietic stem cell transplantation (HCT). Our unit was in need of a standardized tool to assess and treat OM in patients undergoing HCT. Objects: To fi nd an assessment tool to assess OM and to fi nd nursing interventions based on the level of OM. An awareness group was established to develop an evidence based approach to OM in our unit. Method: Data collection consisted of a literature search in Cochrane, PubMed and Cinahl using the keywords oral mucositis, HCT assessment and intervention. The results were limited to research published after 2000. Results: Based on data collection, the group developed an interdisciplinary evidence based procedure and a standardized care plan. The literature search found that grading OM is done increasingly worldwide. The World Health Organization Oral Toxicity Scale (WHO) was chosen because it is validated and tested on a wide range of cancer patients receiving both HCT, chemotherapy and radiation. The group chose to systemize interventions based on the level of OM. This was done using the WHO. Education for the nursing staff on grading OM and how to use the procedure and care plan was provided by the awareness group. Individual training in assessing OM was done bedside by a member of the awareness group. Empowering the patient is important to succeed with the interventions. What the patient can do and how nurses educated them is described in detail in the procedure and care plan. Conclusion: The nurses' awareness on OM has increased and the care is more quality assured. These interventions are inexpensive and require no more than the usual staff. Interdisciplinary approach to OM is necessary to succeed with interventions. Equally important is patient involvement and a thorough implementation plan. The experience so far is that the patients are empowered by learning interventions they can follow up themselves.
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A retrospective audit looking at the implementation of the POTTS score and its use in predicting which patients deteriorate further with the bone marrow transplant setting
T. Marler-Hausen, S. Zulu, M. Smith Kings College Hospital NHS Foundation Trust (London, UK)
Patient Observation Track and Trigger (POTTS) score identifi es unwell patients so that they can be highlighted to senior members of the medical team and managed in a way that aims to prevent the decline in health. We carried out an audit to fi rstly determine effective implementation of POTTS score on the bone marrow transplant (BMT) unit and secondly to determine whether it is effective predictor to identify patients who deteriorate further. Methods: We retrospectively collected vital sign and POTTS score data on BMT patients over a 3 month period at King College Hospital. We audited 50% of patient notes and reviewed in detail all patients who deteriorated further. The audit examined observations charts and POTTS scores to identify the highest POTTS score and compliance rates. Results: 67 patients were admitted for BMT, 35 patient casenotes were audited (19 Allo, 16 Auto). 3% (n=2) were admitted to the Intensive Care Unit (ICU) and subsequently died. A total of 5259 observations were completed and 98.2% had a POTTS score. Autologous recipients had an average of 122 observations with an average highest POTTS score of 2.7 (range 0-6). Average length of stay was 24.6 days (range 17-40, SD 6.76). Allogeniec recipients had an average of 173 observations with an average highest POTTS score of 5 (range 0-12). Their average length of stay was 35.1 days (range 23-54, SD 13.6). Discussion: Compliance with POTTS scores was favourable at 98%. The relevance of POTTS scores in the BMT setting is more diffi cult to defi ne since there is a well defi ned risk of infection and patients are managed following a specifi c neutropaenic sepsis protocol. Therefore, despite having a high POTTS score, patients can still managed in the same way. The two ICU patients had a noticeable difference in their POTTS score during the 72 hours and immediately before ICU admission but were both extremely unwell. Conclusion: High POTTS scores can identify unwell BMT patients. However, a low score can be present in seriously unwell patients. This reinforces the importance of clinical assessment alongside scoring systems. We are developing a nurse led morbidity and mortality meeting to help focus on the associated nursing issues and interventions. A simple audit tool will be developed to evaluate practice and identify trends for the future. In collaboration with the ICU teams we will facilitate education and development and highlight the importance of critical care issues in BMT patients.
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The benefi ts of having SOPs to safe PBSC collection in the smallest children (≤ 10 kg): the Clermont-Ferrand paediatric experience, France V. Hervé-Sequeiros, E. Rochette, C. Lallemant, A. Laverroux, E. Lopez, C. Sozeau, E. Merlin, J. Kanold, F. Deméocq CHU Clermont-Ferrand (Clermont-Ferrand, FR) Our unit is composed of 4 paediatric nurses and 1 paediatrician, we have JACIE accreditation from 2006. Since 1991, 60 PBSC collection procedures were performed in 31 children weighing 10 kg or less (average 8.9kg, range 6.2-10). SOPs for collection are available and required: 1/specialised physician/nurse consultation to answer of the needs of these children and their parents. It's at this time that a reliable relation is established, it's indispensable for the good progress of the collection, in particular for the patients coming from the other centres (30 % of our collections). 2/ Specifi c team need: 2 nurses for 1 patient. 3/ SOPs also consist of algorithm for venous access. From 1991 to 2000, 93.8% of the PBSC collections were realised with lines inserted especially for this procedure while only 41.8% after 2000, (remains 58.2% were realised with a central was routinely inserted at the initial diagnosis plus peripheral venous access). 4/ With an average of 0.77L patient's blood volumes (range 0.47-1.13), there is more hypovolemic risk. To limit the risk we have a SOP for priming cell separator with the red blood cells (30% of procedures). Acid-citrate-dextrose (ACD) was used as an anti-coagulant at the minimum achievable ratio according to the special SOP. To prevent hypocalcemia, Calcium gluconate was systematically administered. Hypothermia was prevented in all patients with woollen blankets and hotwater-bottles. Body temperature and diuresis were carefully monitored. Our experience shows that successful PBSC collection is based on most important factors: experimented paediatric physician and nurses, pleasant and adapted place to the children and reliable climate. To concluded, in small children, a specially adapted patient approach is necessary to decrease the procedure related stress.
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Use of transparent fi lm in Hickman's catheter R.C.C.P. Silveira, C.M. Galvão, F.T.M. Braga, L.M. Garbin University of Sao Paulo at Ribeirao Preto (Ribeirao Preto, BR)
Objectives: to analyze the use of transparent polyurethane fi lm in Hickman's catheter in patients submitted to allogeneic hematopoietic stem cell transplantation (HSCT) and the frequency of catheter-related infection and cutaneous toxicity. Background: dressings are a nursing intervention aimed at preventing central venous catheter (CVC) infection. With regard to coverage, a range of materials is used as dressings. In patients submitted to HSCT, the advantage of using transparent fi lm is its longer dwelling time, decreasing skin irritation. Methods: A series of cases was studied, involving subjects aged 16 years or older; they were candidates for related allogeneic HSCT and surgically implanted a Hickman line. The independent variable was the OpSite™ polyurethane dressing, with changes programmed every seven days. The dependent variables were: cutaneous toxicity and CVC-related infection. Data were collected between August 2007 and July 2008. The study received approval from a Research Ethics Committee. Results: the series consisted of 10 cases. The mean CVC assessment period was 28 days. Due to the presence of exsudate, the use of transparent fi lm became impossible within the fi rst 12 days on the average. The mean usage time of sterile gauze dressings was 12.9 days, against 15.1 days for the fi lm. Early removal of the catheter due to infection occurred in four cases. The maximum degree of toxicity occurred in one case using gauze dressing and in three cases using fi lm dressing. Conclusions: surgical implantation of the CVC followed by the start of the conditioning mechanism seemed to prolong the presence of exsudate. Transparent fi lm permitted visualization of the catheter exit site and changes at longer intervals.
Symptoms management P1373
A team approach to nutritional care P. Sweeting, J. Braithwaite, J. Beauchamp University Hospitals Bristol (Bristol, UK) Introduction: The nutritional challenges facing patients undergoing Stem Cell Transplant (SCT) are well recognised. The Bristol Bone Marrow Transplant Unit uses a team approach to educate, assess, plan and implement appropriate nutritional interventions for our adult and paediatric patients. Objective: Through each stage of our patient's pathway we aim to provide effective communication, assessment and interventions to optimise our patient's nutritional status. We seek to involve and empower our patients and their carers to assist them in retaining some control and input into their ongoing nutritional care. Method: Using all members of the multidisciplinary team (MDT) including nurses, housekeepers, dietician, medical staff, pharmacist and play specialists we individualise our standard assessment tools and care plans to identify and meet the needs of each patient. Our safe eating protocol guides food selection and preparation for the fi rst 100 days of SCT. A comprehensive menu of food is stored and prepared in our ward kitchen where a dedicated team of housekeepers, supported by the nursing team offer a diverse and safe range of food and drink 'on demand'. As and when additional nutritional support is required we are able to offer and provide calorie supplements, naso-gastric feeds and parenteral nutrition, either singly or in combination. Results: Patient and carer feedback is sought prior to planned discharge using a patient satisfaction questionnaire. These fi ndings are reported to the MDT and as appropriate our nutritional care programme is reviewed and changed. Conclusion: The MDT works together within a clear and concise communication system to identify, implement and evaluate the nutritional needs of patients during their whole SCT pathway. Essential to our success is the identifi cation of who is doing what, why and when.
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Audit of BMT antibiotic febrile neutropenia guidelines R. O'Donnell Bristol Royal Hospital for Children (Bristol, UK)
The Bone Marrow Transplant (BMT) antibiotic febrile neutropenia guidelines were updated in 2009. Due to national guidance on prudent prescribing of antimicrobials this is a priority for audit (1). Objective: To assess whether choice and monitoring of antibiotics prescribed for febrile neutropenia follow trust guidelines. Method: A retrospective audit was conducted of consecutive patients admitted to the ward. Patients were included if they experienced an episode of febrile neutropenia. Prescribing was audited against the following standards; 1. Patients prescribed piperacillin/tazobactam (P/T) and gentamicin for fi rst febrile neutropenic episode. Patients with penicillin allergy or those with recent culture positive infection sensitive to agents other than P/T and gentamicin were excluded from the criteria. 2. Gentamicin trough level taken before second dose, then twice weekly (stat doses excluded). 3. Vancomycin trough level taken at 24hrs, then twice weekly (treatment ≤ 1 day excluded).
Results: Seventeen of 21 patients met the inclusion criteria. Standard One: Fourteen patients received P/T plus gentamicin as fi rst line therapy. Alternative antibiotics were prescribed due to penicillin allergy, renal impairment and microbiology advice. Therefore overall compliance was 88%. Standard Two: Sixteen courses of gentamicin were prescribed. Trough levels were measured before the second dose for 15 courses (94%). For the nine courses that continued, trough levels were taken at least twice weekly. All levels were within range with the exception of one patient with renal impairment. Standard Three: Twelve patients received a course of vancomycin. A trough level was taken at 24hrs for ten patients (83%). Levels were monitored at least twice weekly for all patients who continued vancomycin, although 32% were sub-therapeutic (<5mg/L). Discussion and Conclusion: The choice of initial antibiotics was generally in accordance with BMT guidelines. Alternative antibiotics were prescribed due to renal impairment and microbiology advice, which are reasonable exceptions. Gentamicin was monitored appropriately. Vancomycin dosing could be optimised as a third of levels were sub-therapeutic, risking treatment failure and resistance. This will be disseminated to BMT consultants with a proposed review of vancomycin dosing.
[1] Department of Health, Health Protection Agency, Dec 08. Clostridium diffi cile infection: how to deal with the problem.
P1375 Patient needs throughout total body irradiation L. Bacalhau IPOLFG (Lisbon, PT)
Total Body Irradiation (TBI) is a radiotherapy technique that distributes a uniform dose of radiation all over the body, which is also combined with a high dose of chemotherapy in allogeneic bone marrow transplant. The radiation effect is felt in all the cells that have a rapid growth and/or a poor regenerative function. In order to take an advantage of this situation, the irradiation is normally given in several fractions, two or three times a day during one to fi ve days, allowing the normal cells of the tissues to regenerate and tolerate the treatment while increasing chances of the irregular cells being destroyed. The main purposes are: destroy residual malignant cells, suppress the host immune system to diminish the risk of rejection in allogeneic transplant, free up space in the bone marrow in order to graft. TBI is part of treatment protocols in allogeneic bone marrow transplant patients diagnosed with leukemia and Hodgkin´s Lymphoma. This study has the purpose of assessing the incidence of the main early secondary effects (nausea, radiodermatitis) and determines the main discomfort felt during the TBI sessions to know the patient's experience and adjust the nurse care interventions. To collect these information's where analyzed the patient's nursing records which had been submitted to TBI troughout the year of 2009 and 2010. A sample of only 10 pacients was found, 8 of which had the same conditioning: ciclofosfamid and TBI fracioned in eleven sessions, two patients where known to present fl udarabine and a single session of TBI. These two patients were the only that didn't present radiodermatitis. The remaining eight patients had radiodermatitis, grade one. Assessing the incidence of the nausea symptom, 50% of the patients have manifested it, needing SOS medication. When questioned about the main cause of discomfort related to the session of treatment, they named: the long duration of the treatment (n=10), the need to remain immobile (n=4), and the weight of the thyroid region protection, which caused an asphyxia sensation (n=3). According to this study the supply of information about the positioning and the environment during the sessions of radiotherapy, the clarifi cation of doubts, the demystifi cation of fears and misconceptions concerning radiotherapy, the teaching about the application of the moisturizing cream, the nausea assessment and the administration of antiemetics are the most relevant nursing interventions.
P1376 To transfuse or not to transfuse? S. Vieira, D. Monroe, A. Donkin, M. Madziwanzira, M. Librojo, N. Amin, H. Chipudhla, L. Porin, M. Palomar, L. Chavez, C. Bernardez The Trustee of London Clinic (London, UK)
Introduction: Blood transfusion continues to be an essential part of modern practise, but it is not without risk. During the last decade there has been an increased interest in the national level of transfusion practice across the United Kingdom (UK) and Europe. This data is collected on behalf of Serious Hazards of Transfusion (SHOT). Therefore avoiding unnecessary transfusions is accepted as one way of reducing the risk which can be associated with blood transfusion. In our stem cell transplant unit we have audited red cell transfusion frequency and the
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S435 reason for that transfusion. The hospital policy is to maintain an haemoglobin trigger of 8 g/dL or to transfuse if the patient is clinically compromised. Method: The audit was carried out prospectively. A 'log in' book was kept on the Unit for recording the red cell transfusion orders. The data was validated with cross check retrospective inpatient records on a monthly basis. The audit was carried out over a 6 month period, form May 2010 until the end of October 2010.
Result: During this 6 months period a total of 90 episodes of RCT were performed in our unit. The haemoglobin levels were 8.5 gr/L or below in 75.5% episodes, where as only 11% of other transfusions performed were because of a haemoglobin level was 9.1 gr/L or above. The reason for transfusion was categorised as: routine, as per unit protocol, bleeding, pre-procedure and on doctor's instruction due to patient symptoms or keeping a high thresh hold haemoglobin level. Routine RCT was 87% of total episodes and 76% of this fi gure was with an Hb of 8.5 gr/L or below. However 10% of the RCTs were performed when the haemoglobin level was 9.1 gr/L or higher. Conclusion: Our organisation recognises the importance of risk associated and unnecessary blood product transfusion. Our 6 months audit has shown interesting fi gures. 10% of total episodes RCT was given as routine were above 9.1 gr/L where as 70% of routine RCT was performed due to low haemoglobin level according to our unit policy. It is suggested that further studies are performed in order to monitor compliance with hospital policy.
P1377 Evidence-based mucositis protocol working group in paediatric bone marrow transplant unit in Israel A. Gutkind, J. Szabo, Y. Lapshin Sheba Medical Center (Ramat Gan, IL)
Oral mucositis is a common and often debilitating complication of cancer treatment, often requiring hospitalization and intravenous(IV) narcotics to relieve pain. Mucositis is the painful infl ammation and ulceration of the mucous membranes lining the digestive tract. In severe cases it results in malnutrition and dehydration requiring IV nutrition (TPN).In children also resulting in decreased treatment compliance. Purpose: To establish an assessment tool and treatment and prevention protocol for pediatric population that was evidence based. Method: A working group of 5 pediatric general and oncology nurses was established in the BMT and hemato oncology department in "Safra Children's Hospital" (SFH).meeting over the course of 6 months. The group preformed a thorough literature review and investigation of existing treatment protocols at various medical centers worldwide. We found that an assessment tool for the pediatric population does not currently exist. Results: 1) An assessment tool for use in the pediatric hemato oncology department of the SFH was written. 2) A protocol for prevention and treatment was drafted. This would allow Registered Nurses (RN) with advanced training in oncology and Intensive care to independently assess children at risk for developing mucositis and those already suffering from it. They would subsequently plan and implement care and treatment without the need for doctor referral. This would save valuable time in bringing relief to these children, as well as empowering the nurse's position within the multi professional staff. 3) This process advanced the status of the general pediatric nurse, treating mucositis, as well as improves the interdepartmental communication. Creating a baseline for consultation on the subject. Conclusion: Since implementation of the assessment tool and treatment protocol there has been an increase in staff awareness and knowledge of the need for timely prevention and treatment of mucositis and its complications. This process also resulted in fewer hospitalizations for mucositis and its complications. It is our goal to continue to update potential treatments among BMT and hemato oncology patients.
P1378 Help, my patient has graft-versus-host disease of the guts! R. J. de Weijer, L. Schoonhoven UMC Utrecht (Utrecht, NL)
A few years ago we got a lot more to do with patient suffering from graft versus host diseases (GvHD) of the guts. We as doctors and nurses felt powerless and faced with a tremendous workload. One nurse can take care for one patient in her swift; infusion therapy, the daily care and many pots. We also found it very diffi cult to give good care, the uncertainty about the future of the patient was hard to handle. Together we have developed a process in which the patient, the nurse and the doctor together agree on how to proceed. This has provided much clarity. Because of this we had the opportunity to go on. We have also started registering of symptoms. After a literature survey of patients' compliance at GvHD of the guts: we know which symptoms we can expect. So we make a registering list of all the symptoms which we know. We registered symptoms/ compliance which the patient experiences the most. With all these data we had made a list of top twelve most common complaints. With this list we can give better care, because we know with which symptoms we have to deal. In this presentation we will give you an impression of how we worked with a communication list and a symptoms score form: the result of our survey. Now we have been concentrating on interventions. We know what the most common symptoms are and we want to give the best care we know. We want to improve the care for each patient. Now days we are made a list of the interventions which we can use by taking care of the patient. The interventions we had found are multidisciplairy; medical, nursing and psycho-social. We still are trying to improve the interventions; but that is a long process, because we don't have a lot off patients each year. We know the interventions we are using or will be developing in the future cannot be evidenced based; but it will be our best care. Beside also the medical treatment for GvHD at the gut is going to be better: Most patients get mesenchymal stem cells; which seems to give good results. The future will not been always dark for these patients. Still will be there always patients who has severe GvHD and needs our help and best care.
P1379 Prospective evaluation of oral mucositis in children undergoing stem cell transplantation M. Yilmaz, S. Cagan, S. Aksoylar, S. Kansoy University of Ege (Izmir, TR)
Oral mucositis (OM), one of the most debilitating and painful side effects associated with stem cell transplantation (SCT). The prevelance of OM in SCT patients has been reported very high rates (>80%). Since aim of this study was to investigate frequency and severiy of mucositis and to relate the fi ndings to some demograiphic data in a group of children undergoing SCT from admission to the hospital for SCT until discharge. Method: The study design was prospective and descriptive Study setting was pediatric bone marrow transplantation unit with three beds of a university hospital in Izmir-Turkey. The sample was consisted of 29 pediatric patients (20 males, 9 females, medain age 98 ± 49.5 months) undergoing SCT. They were followed from September 2008 to October 2010. Data were collected at fi ve different time-points;T1 (conditioning regimen week), T2 (the day of stem cell infusion), T3 (fi rst week following SCT infusion), T4 (second week folllowing stem cell infusion) and T5 (third week of stem cell infusion). All patients had an oral examination using Oral Assessment Guide (OAG) and World Health Organization Mucositis Assessment criteria; also pain and swallow assessments daily discharged from SCT unit. Data from oral clinical exams were used to calculate the OAG for each patient at each visit. Pain assessment was done using by Wong-Baker Faces Pain Rating Scale and patients' self-reported words. The conditioning therapy was heterogenous and no total body irradiation. McNemar and repeated measures anova tests were used. Results: SCT was done as therapy for nonhematological diseases (21 patients, 72.4%) and hematological malignancies (9 patients, 27.6%). Twenty seven children (93.1) were received allogeneic transplants and two (6.9%) were autologous.OM was most frequent in T3 (n:16, 55.2%) and T4 (n:9, 31%) respectively (p<0.01).The mean peak OAG score was the highest in T4 (mean ± SD: 9.97±1.09). Also oral pain was most frequent in T3 and T4. No signifi cant differences were found between OM and diagnosis, gender and age, type of transplantation, enteral nutrition and total parenteral nutrition (p>0.05). In conclusion, our results shown that OM development, the mean peak of OAG score and oral pain are mostly frequent fi rst and second week of stem cell infusion. SCT nurses play a vital role in to reduce the incidence and severity of this common problem. The patients must be followed very closely for effective mucositis management.
P1380
Frequency and intensity of nausea-vomiting, diarrhoea, pain, and fatigue in children undergoing stem cell transplantation
S. Cagan, M. Yilmaz, S. Aksoylar, S. Kansoy University of Ege (Izmir, TR)
Common symptoms such as nausea and vomiting, diarrhoea, pain and fatique may have a negative impact children's ability to function and on their quality of life during and after stem cell transplantation (SCT). Aim: The aim of this study was to describe in frequency and intensity of symptoms from admission for stem-cell transplantation (SCT) until discharge from the unit. Method: This study's design was prospective and descriptive. At the time the study was undertaken between September 2008 and October 2010.Study setting was pediatric bone marrow transplantation unit (three bed) of a university hospital in IzmirTurkey. The sample was consisted of 29 pediatric patients (20 males, 9 females, medain age 98 ± 49.5 months) undergoing SCT. Data were collected at fi ve different time-points;T1 (conditioning regimen week), T2 (the day of stem cell infusion), T3 (fi rst week following SCT infusion) , T4 (second week folllowing stem cell infusion) and T5 (third week of stem cell infusion). All patients had vomiting, diarrhea, pain and fatigue assessments performed daily discharged from unit SCT. Vomiting and diarrhoea were assessed according to National Cancer Institute Common Toxicity Criteria (NCI). The Visual Analog Scale was used to assess fatique. Pain assessment was done using by Wong-Baker Faces Pain Rating Scale. The conditioning therapy was heterogenous and no total body irradiation. McNemar and repeated measures tests were used. Results: SCT was done as therapy for nonhematological diseases (21 patients, 72.4%) and hematological malignancies (9 patients, 27.6%). Twenty seven children (93.1) of 29 patients were received allogeneic transplants and remaining two (6.9%) were autologous. Nausea-vomiting was most frequent in T1 (n:23,79.3%) and T3 (n:16,55.2%). Diarrhoea was most frequent in T3 and T4 equally (n:13, 44.8%) (p<0.05). Pain main scores were most found highest in T3 (1.02±1.5, min-max:0-6) and T4 (1.02±1.5, min-max:0-6). Abdominal pain was found mostly among the patients. Fatique mean peak score was highest in T3 ( 6.5±3.1) and T4 (6.5±2.9)(p<0.05).
Conclusion: Nausea and vomiting, diarrhoea, pain and fatique were identifi ed as the most common symptoms and were seen mostly in the early days after stem cell infusion in this. • Characterization of the Degree of Pain Grade 0 -52% Group B and Group A 48% Grade 1 -62% Group B and Group A 38% Grade 2 and 3 -Group A 78% -grade 2 and 54% -grade 3, Group B 22% -grade 2 and 46% -grade 3; Grade 4 0%.
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• Characterization of Parenteral Feeding It appears that most of the individuals, who had undergone this type of food, were in Group A by 83%. Group B had 17% need to receive parenteral nutrition.
• Characterization of application of morphine It appears that was more frequent application of morphine to individuals in group A 57% compared to group B 43%. Conclusion: The study revealed no statistically signifi cant differences in the criteria for the degree of oral mucositis and the degree of pain, regarding the need for nutritional support with parenteral nutrition and the need for analgesic therapy, with use of morphine, data suggest that these needs have decreased in group B.
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Prophylaxis of oral mucositis in patients treated with haematopoietic stem cell transplantationL.J. Pomper, A. Ostojic, R. Jakovac, V. Stuzic, S. Zemljak, M. Vukelic, I. Zivotic, I. Sikic, M. Krpecanec, K. Petkovic, M. Farkas, Z. Vukorepa, M. Smiljanic, N. Dubrovic, S. Blazevic, T. Elez, V. Kvesic, R. Vrhovac University Hospital Merkur (Zagreb, HR) Background: Oral mucositis (OM) is a frequent side effect following hematopoietic stem cell transplantation (HSCT) consequences of which affect life quality of patients (pts).
S437
Objective: to determine frequency, intensity, duration and consequences of OM by testing effectiveness of standard OM monoprophylaxis in comparison with OM combination prophylaxis. Patients and methods: records from 25 consecutive pts enrolled in an ongoing prospective study (Table 1) , treated with autologous (auto) HSCT (22) or allogeneic (allo) HSCT (3) from April until October 2010 were analyzed. Conditioning protocols were: HD-melphalan (7), Flu/Bu/ATG (2), Bu-Cy (2), BEAM (10) and BEAC (4). All pts received antibacterial and antifungal prophylaxis and allo HSCT pts, in addition, received antiviral prophylaxis. Pts are divided into 3 groups (sr, src and srg) based on randomly received OM prophylaxis: standard rinse (SR) (aqua redestilata, chlorhexidine, bicarbonate pulver), SR+Caphosol ® and SR+Gelclair ® , respectively. Data on frequency, duration and intensity of OM, pain in oral cavity and use of opioid analgetics were compared between these 3 groups. The grade of OM was evaluated according to the WHO scale. Results: 84% of pts (sr, src, srg=100%, 70%, 86%, respectively) developed OM, 20% of them developping OM of WHO grade 3. Median duration of OM was 8 days (mean 9.76, range 1-33, SD 6.94) and median OM grade was 2 (mean 1.76, range 1-3, SD 0.83). Median in-hospital time from start of conditioning was 19 (mean 20.28, range 15-37, SD 4.91). 52% of pts experienced pain in oral cavity (sr, src, srg=75%, 43%, 33%, respectively) and 28% were receiving opioid analgetics (sr, src, srg = 50%, 20%, 14%, respectively). Table 2 shows data for each group of pts. Conclusion: Prophylaxis of OM plays an important part in nursing practice and demands coordinated measures between physicians, nurses and patients. Our analysis shows that OM is more frequent and appears in more severe form in pts treated with monoprophylaxis than in those treated with combined prophylaxis. Patients treated with combined prophylaxis had less frequent oral cavity pain, and those who had it, experienced it in lower intensity. However, this is just a preliminary report of a study that is still in progress. Further research on a greater number of pts is warranted. Cytomegalovirus (CMV) reactivation can be a serious infectious complication in patients who have undergone allogeneic haemapoetic stem cell transplant (HSCT). The use of immunosuppressants in this patient group is a well recognised contributing factor of CMV reactivation. This is a single centre, retrospective study looking to ascertain whether the type of immunosuppressive therapy given in the pre HSCT conditioning regimen had any infl uence on CMV reactivation post transplant. A total of 31 patients post matched sibling or volunteer unrelated donor allogeneic HSCT performed between 2007 and 2010 were analysed. Of those 14 patients had received conditioning using Fludarabine, Busulphan and Campath 1H (FBC) and 17 received Fludarabine, Busulphan and Anti-thymocyte globulin (FBA). In addition, the degree of donor mismatch, the presence of acute graft-versus-host-disease (GVHD) and concomitant immunosuppressive treatment were also evaluated. Peripheral blood CMV-PCR was monitored twice weekly from start of conditioning. Time to reactivation, length and type of treatment required were reviewed and compared between the two groups. In each group, 10 patients were at risk of CMV-reactivation due to positive CMV serology in the patients, their donors or both. In the FBC group, 9 patients (90%) had reactivated CMV within the fi rst 30 days of HSCT whilst in the FBA group only 7 (70%; p=0.58) Of those that reactivated in the FBC group, the median length of treatment required was 38days (min 9, max 179) which was mainly intravenous ganciclovir. In the FBA group the median length of treatment required was 26days (min 20, max 72) which was mainly oral valganciclovir. In the FBA group 4 patients had a mismatched unrelated donor and in the FBC group only 2. However, the incidence of acute GVHD (grades I-II) and concurrent treatment with steroids plus cyclosporin A was higher in the FBC group (FBC=70%; FBA=30%). Conclusion: Although not statistically signifi cant, there was a trend in increase of CMV reactivation in the group receiving FBC conditioning, most of which required inpatient therapy with IV ganciclovir. However, the incidence of GVHD was also higher in this group and may have contributed to the increased incidence of CMV reactivation (in addition to the immunosupression caused by Campath). Patients with complex medical post transplant complications require higher levels of nursing intervention and often have a longer inpatient stay.
Education and support of nurses
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Developing nurse competency in bone marrow biopsy: a structured training programme
L. McNamara The Royal Marsden NHS Foundation Trust (Sutton, UK)
Haematopoietic stem cell transplant (HPCT) patients routinely undergo bone marrow biopsy procedures to provide a diagnosis and evaluate the effectiveness of treatment. Traditionally these are performed by physicians, but it has been suggested that a nurse practitioner model improves the effi ciency of a haematology unit and increases the quality of patient care. At the Royal Marsden Hospital (RMH) in the UK, specially trained nurses perform on average 80 bone marrow biopsies per month. A review showed that no structured bone marrow biopsy training module was available for nurses. Due to interest, a new course was subsequently developed at the RMH for those working in haematology to gain the knowledge and skills necessary to perform bone marrow biopsies. The course comprised two theoretical and simulated practical days in the classroom, followed by one day in clinical observation. Six delegates from hospitals across the UK attended the inaugural module. A specially formulated workbook was also provided to guide trainees through the programme and ensure that key learning outcomes were met, including an understanding of: the indications for performing a bone marrow biopsy pertinent anatomy and physiology legal and professional issues patient preparation and after care problem prevention and resolution dealing with complications
Also, key to the module was for participants to perform procedures in a simulated environment using part-tasks and bone marrow biopsy equipment. A day in clinical observation allowed trainees to gain experience in the logistics of a nurseled service including documentation, information, consent and conscious-sedation. An evaluation by delegates highlighted the importance of: translating theory into practice and that competency protects patients and practitioners being trained by a nurse colleague who understands the trainees role simulated training which helps to overcome fear and helps make the transition from assistant to practitioner With motivated staff and a structured training programme, it is possible for nurse practitioners to perform the techniques of bone marrow biopsy and obtain specimens of satisfactory quality. This new module aims to help ensure that knowledge and skills are optimally developed to support best outcomes for patients. It is hoped that by sharing this training process, we will encourage dialogue and thereby continue to maintain and improve the standards of HPCT nursing care in Europe.
P1385 The East of Scotland Haematology Nurse Group use of the virtual classroom environment in the provision of continuous professional development through a Macmillan online lecture series K. Campbell, J. Horn on behalf of the East of Scotland Haematology Nurses Group
The East of Scotland Haematology Nurses Group (ESHNG) are dedicated to the provision of Continuous Professional Development (CPD) of Scottish haematology nurses that often work in isolation across the country with little opportunity to network and share practice, by awarding education grants and holding an annual study day. To build on this principle and after taking into consideration a recent evaluation of participation in an online learning environment within the Therapeutic Options in Malignant Haematology Module run at Edinburgh Napier University (Campbell 2009); the ESHNG were interested in the potential use of virtual classroom facility in provision of CPD for all haematology nurses across Britain. The ESHNG were successful in obtaining funding from Macmillan Cancer Support to provide sessions every month, for a year, facilitated by an experienced operator, for fi fty nurses over the internet. The speakers would be determined by the group and the attendants depending on the topic of speciality requested. There would also be a chance to conduct either case presentations or journal clubs once a month in small group sessions. The intention was to meet the learning needs of the participants by the use the virtual classroom to critically engage with current practices in malignant haematology, with a diverse network of colleagues, building a learning community whilst gaining additional computer skills. Introduction: Central venous cannulation with peripheral access in patients with malignant hemopathies is a fundamental scientifi c and technical indicator in the nursing practice. One year ago, owing to the complexity of hematological patients, we decided to carry out a comparative study between traditional insertion versus Bacteremia Zero protocol. As there are hardly any records on insertions outside of the ICU or x-ray diagnosis, we focused on the approach used on the hematology ward. Objective: To confi rm whether or not there are statistically signifi cant differences between catheter insertion and maintenance related infections before and after «Bacteremia Zero» Protocol is applied. Material and methods: A descriptive analysis was performed. 20 patients were included prospectively and another group of 17 patients retrospectively for historical control.All the staff involved attended the «Bacteremia Zero» course. All venous access was central Drum-type peripheral access.A special cabinet was made for central access lines with a checklist to ensure correct implementation and compliance with the control practice during insertion and maintenance. Results: 38 patients were studied, of whom 21 patients (group A) were studied prospectively and 17 retrospectively for the historical control (group B). The mean age was 54.6 years (range 35-72), and sex distribution: 78.94% men and 21.05% women. Group A: During insertion, a skin cleansing with dilute chlorhexidine was conducted. Subsequently, chloroethyl was sprayed on in order to anesthetize the area. Barrier measures consisted of a sterile fi eld and sterile gloves throughout the procedure. Three access lines were removed due to fever, chills and negative blood cultures. Group B: The measures taken in this group consisted of the same as in group A, but using 2% chlorhexidine and reinforcing barrier measures and hand hygiene. Sterile gowns, surgical caps and masks were used. In addition, a collaborator joined the project, who took the same measures. Three access lines were removed due to fever and chills, in which there was a positive blood culture of Klebsiella. The data analysis was undertaken based on a bilateral Fisher's exact test with α=0.05, p = 0.4879. Conclusions:There are no statistically signifi cant differences between both groups as regards to nosocomial infections, although the mean number of days in which the catheter is kept in is in favour of Bacteremia Zero (20.75 days).
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What are the nursing skills and knowledge required to look after adolescent bone marrow transplant patients?
K. Maxwell, T. Clarke, J. Armoogum University College London Hospital (London, UK)
Introduction: Adolescent bone marrow transplant (BMT) patients are cared for in the Children's and Young Peoples Cancer Service (CYPCS) at University College London Hospital. We asked CYPCS nurses what skills and knowledge they felt are needed to confi dently care for adolescent BMT patients. Method: All CYPCS nursing staff sent questionnaire about skills and knowledge needed to care for adolescent BMT patients and elicit views on further training. Topics included stem cell source, BMT specifi c drugs and side effects. 37 nurses approached, 17 (47%) responded. Results: All nurses in sample were qualifi ed (band 5; n=6, 35.3%, band 6/7; n=12, 65.7%). 23.5% (n=4) had external BMT course, 35.3% (n=6) learnt from senior staff/Clinical Practice Facilitator (CPF), 35.3% (n=6) read books/leafl ets and 41.2% (n=7) learnt on job. 5.9% (n=1) felt they received no teaching. Overall confi dence: 35.3% (n=6) 'totally' confident talking to patients about BMT, 41.2% (n=7) 'a bit' confident, 23.5 % (n=4) 'not really' or 'not at all' confi dent. Skills and knowledge: Majority (76.5%, n=13) happy with their BMT knowledge and felt safe caring for patients. Remainder 'slightly' happy (11.8%, n=2) or 'unsure' (11.8%, n=2). 52.9% (n=9) knew difference between autologous and allogeneic BMT and happy to explain to patients, 11.8% (n=2) knew difference but not to explain to patients, 23.5% (n=4) 'sort of' understood difference and 5.9% (n=1) felt they did not. 35.3% (n=6) confident about knowledge for majority of post BMT complications, 58.8% (n=10) about some and 5.9% (n=1) not confi dent. 64.7% (n=11) familiar with most drug rationales and 35.3% (n=6) with some. No-one totally unfamiliar. Education: 76.5% confi dent accessing information or support for patients, 5.9% (n=1) information only, 11.8% (n=2) support only. 5.9% (n=1) felt they did not know. 76.5% (n=13) want more BMT training and of those, 52.9% (n=9) external course, 11.8% (n=2) work with CPF, 47.1% (n=8) internal teaching and 11.8% (n=2) written information. Conclusion: Whilst overall most nurses confi dent and happy with BMT knowledge and felt safe caring for patients, almost quarter did not feel confi dent and knowledgeable. Study sample small, however results suggest nurses want more BMT education and training. Recommendations: 1) Increased access to BMT external courses 2) Introduce series of internal BMT training days 3) Peer-to-peer learning
P1388 Italian Nurses Group in Mobilization and Apheresis(GIIMA): concepts and action
A. Babic (1), D. Laszlo (1), L. Galgano (2), E. De Marchi (3), L. Orlando (1), M. Clerici (1), F. Mariano (1), G. Martinelli (1) (1
)European Institute of Oncology (Milan, IT); (2)A.O.U. Careggi (Florence, IT); (3)PTV (Rome, IT)
Background: The Clinical Transplantation Program consists in a process performed by a multidisciplinary team working with common staff training, programs, protocols, and quality management systems. Peripheral blood stem cells represent the most used source of hematopoietic cells and apheresis is a routinary technique applied to collect them. The collection is generally performed by National Transfusion Services while the mobilization and reinfusion of stem cells is carried out by Clinical Units. For these reason, there is diffi cult to assure a continuity of patients assistance, especially from a nurse's point of view. Methods: We therefore created in April 2010 a dedicated group (Gruppo Italiano Infermieristico in Mobilizzazione ed Aferesi -GIIMA, with a committee linked to the GITMO and EBMT Nurses Groups. The group includes medical doctors and nurses working in National Transfusion Services and Transplant Centers with the aim to: 1) create the stabile link between the apheresis nurses who works in transfusion centers and those who operates in transplant centers, following both the patients in mobilization and apheresis. 2) create the material for nurses education in apheresis and for patient information 3) develop the program for nurses education in apheresis for new students based by Jacie's regulation and coherent with Italian low. Results: The group supervised the EBMT handbook translation "The Practical Guide for Nurses and Other Health Care Professionals" in Italian language and have distributed it to each Italian Transplant and Transfusion center. Currently the GIIMA is working on DVD realization which will be available on April 2011, and distribute, again to all Transplant and Transfusion Centers in Italy and Swizzerland (Italian Canton). This DVD will be an additional tool for nurse education. It contains interactive presentation of autoPBSC process, from mobilization, apheresis, autoPBSC to follow-up. The next step is to collaborate in developing the specialized university program for apheresis nurse education to be inserted in regional university program REL -SIDEM. The Czech Republic belongs among the distinguished European countries in the number of stem cells transplantations done. In comparison with other countries of the Eastern block it has the highest transplantation activity with regard to the number of inhabitants. In 2009 there were 537 stem cells transplantations done in 10 transplantation centres in the Czech Republic, out of which 210 were allogeneic and 327 autologeneic transplantations. The level of education of general nurses and nowadays also the transformation to the university level of education (B.A., M.A. Degree) is closely connected with the highly specialized care provided during the stem cells transplantations. Nevertheless, this educational trend still exists at higher specialized secondary schools (DiS) at the same time. However, general nurses will now come to practice as well, and they should work in the positions of assistants of general nurses with university or higher secondary education. Among others, the reasons for the transformation of education towards university/higher secondary education were the requirements of EU and the World Health Organization, as well as respecting the factors such as the age and the psychic maturity of non medical staff on the performance of their work, but fi rst of all coping with the situations with seriously ill patients, who are often hospitalized in the transplantation units. The survey presents the comparison of the age of nurses, their level of education and practice at the transplantation units within the above mentioned centres in the Czech Republic. It concentrates on the analysis of various factors and it compares the calendar age, the practice achieved at the specifi c transplantation units, the level of education achieved and working position of nurses at various institutions. The method used is a questionnaire research of medical staff in various transplantation centres. The aim of the research is the description of the educational system, its present transformation and the posibilities of whole life education of non-medical staff in transplantation units in the Czech Republic. In spite of the number of differences concerning the level of education achieved by general nurses at the above mentioned hospitals there are some common features that issue from the educational system and the conception of whole life education of non-medical staff in the Czech Republic.
P1390 Enhancing the learning experience for nurses C. Kay Royal Marsden Hospital (Sutton, UK)
The importance of education and continual professional development is vital for all grades of nurses (NHS Cancer Plan 2000) . In the JACIE 4th edition specifi c core competencies for S440 nurses are clearly set out. Standard B3.7.1 states that nurses should be formally trained and experienced in the management of patients receiving Haematopoetic progenitor cell (HPC) transplants. At the Royal Marsden Hospital detailed theoretical and practical training already exist to meet this standard but to enable the nurses and stem cell staff to have a better understanding of the complexities involved in the HPC process a more multi-disciplinary approach, using the stem cell laboratory, was included in this training. A programme was set up to enable the nursing staff to spend a day with stem cell staff and the stem cell staff to spend a day on the transplant unit. Both groups where given time to refl ect on their experiences with a senior member of the team. The benefi ts of this programme were as follows: For the nursing staff: 100% stated that they benefi tted from spending the day with the stem cell staff making them realise the complexity of the processes involved in stem cells preparation 100% felt that it enabled them to build relationships with the stem cell staff. 100% agreed that visiting the stem cell laboratory enhanced their learning and understanding of the HPC process. For the stem cell staff: 100% stated that it enabled them to personalise the HPC transplant proces. 85% felt that building relationships with the nursing teams was very important. 100% of them found it very benefi cial to be able to meet the patients and witnessing the side effects they were experiencing as a direct result of the HPC transplant process. 100% agreed that spending a day with the nursing staff on the wards had enhanced their learning and understanding of the HPC process Limitations: Due to staff shortages on the transplant unit this training experience was only able to be offered to the nursing staff when they were working in a supernumery capacity which was usually during their fi rst month on the unit when their experience of the HPC transplantation process was limited. Conclusion: Although this learning opportunity has proved to benefi t all the staff it would be of even greater benefi t if it could be offered to the nursing staff twice, fi rstly when they start working on the unit and at a later stage when they have a deep understanding of the HPC process.
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Education and support of nursing freshmen to reduce new staff turnover rate in a stem cell therapy centre C. -F. Chang, J.-L. Tang, C.T. Lin, K. Li National Taiwan University (Taipei, TW) Background: Nursing freshmen often have not been well-trained and educated. This coupled with stressful and demanded work often lead to a high quit rate which is 2.9 times that of general nursing personnel in Taiwan. Care of stem cell transplant patients is especially challenging, because nursing staffs face patients' and their relatives' suffering, the complexity of treatment complications, the feeling of losing control of the clinical outcome, and the need to cope with death. Our situation and Continuing Education Program: We expanded a new 6-bed transplant unit in National Taiwan University Hospital in March, 2010. We started training nurses from 6 months prior to operation of the unit. We have 12 new nurses in our team. All of them had no prior experience caring for stem cell transplantation patients and 6 were nursing freshmen. Six nursing freshmen not only received training by the preceptors for three months but also participated in case conferences every two weeks. We also offered a comprehensive and interacting supporting system including advice on psychological adjustment and career planning of individual nurse, either from head nurse or attending physicians. The supporting system worked for both on-duty and off-duty shifts.
Results: From March to November, 2010, we transplanted 35 patients (Auto-PBSCT:16, Allo-BMT: 1, Allo-PBSCT:8, URD-PBSCT:7, Haploidentical-HSCT:3). We found that all new staff nurses experienced excessive workload, shortages of clinical nursing technique & skills assessment and mental support, especially in the face of patients suffering grade III or IV acute GVHD or graft failure, or death. After our education and support program, there was no drop out in all our nurses. They became more confi dent of nursing for diffi cult transplant patients. Good quality of care was recognized and praised by patients and there were no complaints of medical malpractices. We passed the hospital accreditation by "Joint Commission International" in 2010. Conclusions: The result showed that with proper education & support program, novice nurses can cope and continue working in the transplant unit, reducing the turnover rate in nurses working in a stem cell transplantation unit as well as improve the quality of nursing care.
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Improving specifi c paediatric nurse training V. Bernhard, V. Jeantet HUG (Geneva, CH) Introduction: Our unit welcomes children from 0 to 20 years old with hematological and oncological diseases. We perform allogenic stem cell transplantation as well. The nursing staff gives very specifi c and high quality care. New collaborators arrive in our unit regularly with different type of contract (CDI, CDD, interim) Problematic: The integration of the new staff in our specifi c unit is not part of a well organised and standardised process. Some of them, even after several months of working in the unit, had not acquired the necessary level of competence in order to be autonomous and follow the safety measures, in respect to the standard clinical practice. Discussion: Which are the required competences for a nurse in order to be autonomous and safe? How to prepare the welcome of a new collaborator? How to motivate nurses to train new colleagues? How to improve the sharing and follow up of new knowledge between the team and the chief nurse in charge of the unit? Achievement:
Welcome Leafl et of the specifi c unit sent to each new person before he/she starts work so that he/she feels welcomed and can get prepared ahead of time. An « acquisition of specifi c knowledge » document which lists very precisely the necessary knowledge required for the good functioning of the unit at different stages (after 2 weeks, 1 month, 2 months, 6 months) Planning of a 5 weeks training for the new person( CDI, CDD or interim), and change of unit negotiated with the supervisor. Attribution of 2 referents nurses During the training, the new person will spend some time with the nurses of the unit who have a specifi c training (pharmacy, infection prevention, DPI, quality, palliative care…) Reference documents according to the specifi city of the unit have been created in order to uniform the different practices of the health care. Evaluation of the skills done with the chief nurse, the reference nurse and the new person at the end of the training program. Conclusion: This project has just started with two new nurses. The fi rst results seem to be positive. We are planning an evaluation of this new project in 6 months. The nursing department of Haematology-Immunology in the Wilhemina Childeren's Hospital consists of two units. At Unit 1, regular treatment for haematological and immunological disorders, are paediatric nurses working and nurses in training to become paediatric nurses. At Unit 2, Haematopoietic Stem Cell Transplant (HSCT) unit, are HSCT paediatric nurses working and paediatric nurses in training to become HSCT paediatric nurses. The training consists a range of six months. In these six months, the pediatric nurse in training intensively supervised by at least two experienced HSCT pediatric nurses. The section is tested by means of score sheets. These score sheets are prepared on the basis of the most common activities on the HSCT unit. These are dividend into the following criteria points: 1. Prevention and education 2. Care and support 3. Diagnose and therapy 4. Care coordination 5. Reporting and registration 6. Professional attitude 7. Experimental treatments 8. Other activities At all the points of criteria are different activities stated. At these activities the pediatric nurse in training must score them self every two months. There are four options for the score: 1. not working yet on this 2. Began to deepen in the activity 3. Do this under supervision 4. Can this independent, fully meets the criterion The score has to be discussed with one of the two supervised experienced HSCT pediatric nurses. In this training there are three evaluation conversations. This conversation will be attended by the pediatric nurse in training, the supervised nurse, the clearance supervisor and de Senior nurse tutor. During this conversations the score will be discussed as well the experience of the pediatric nurse in training. After six months there will be an evaluation to close the training. It will be closed when most activities will be scored with a 4: Can this independent, fully meets the criterion. When the training is fi nished the pediatric nurse will get a certifi cation. Some activities can not be completed because the pediatric nurse in training did not occur the activities during training This may not be too many activities, but some activities will remain learning point for the future. Although HSCT pediatric nurse, learning points will always exists! With this training there is a clear line to follow, and everyone who starts the training knows the expectations!
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Our story -The past and present of bone marrow transplantation nursing in Tartu University Hospital, Estonia S. Telling, G. Raieste, M. Mõtus, K. Jugar, G. Kõks, A. Kaare, H. Everaus Tartu University Hospital (Tartu, EE) Bone marrow transplantation (BMT) with high-dosis of chemotherapy is common treatment for many haematological diseases. The past and present in department of haematology and BMT in Tartu University Hospital is closely related with children oncology. A sharp increase in the number of oncological diseases among children in the late 80s led to the need of a new dedicated section. The 5th February 1991 is the birthday of department of children's oncology-haematology. The department had 10 beds for children with cancer. In the autumn of 1993 department of intensive chemotherapy and BMT added with 5 beds. The fi rst BMT was carried out 07 June 1993. The beginning was hard: nurses needed training because they had no experience working with oncology patients and physicians trained the nurses in the course of everyday work. The conditions in which the patients came were poor -there was singlebed rooms with toilet and bathtub, but there was no alarm bells, no opportunity to interact with the outside world and also no infusors, perfusors and monitors. In the summer of 2002 department of haematology was joined. Now in the department were treated small children, as well older people and BMT patients. It was a challenge to the nurses who need to be able to cope with both children and elderly patients, as well as BMT patients with special care. At the end of 2008 the new hospital building was ready and in January 2009 we moved to new rooms, which offer better opportunities for work and treat patients. We currently have 28 beds, 10 of them are for BMT patients. Since 2010 the cytostatics are centrally dissolved in a hospital pharmacy. This gives nurses a lot more time with patients. Despite our history and the present diffi culties of the work we have done a great job with our doctors. Since 1993 performed 282 BMT -200 autologous BMT, 43 cases with relative donors and 39 cases with international registry donors. Stem cells were collected 187 cases from peripheral blood, 92 cases from bone marrow and in 3 cases it was necessary to use both. In 7 cases 5 patients are transfused the donor lymphocytes. We act on behalf of that reality could be a nurse-specialist training for oncology nurses. By now, the new nurses recruited as soon as possible following compulsory courses: Chemotherapy ABC, resuscitation and blood components and their use. In addition to other training opportunities and needs within.
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Meeting the educational needs of staff on the Oxford bone marrow transplant unit L. Rowley, D. Wareham, M. Ellis Oxford Radcliffe NHS Trust (Oxford, UK) Bone marrow transplant nursing is a multifaceted and challenging speciality. If Bone Marrow Transplant (BMT) nurses are to achieve and maintain excellent standards of patient care, they need to be supported through their learning, to develop, the knowledge and skills required to meet the complex needs of the BMT patient. The purpose of developing an educational programme is to:
Promote excellent standards of BMT nursing care Foster the professional development of nurses, individually and collectively Be responsive to changing trends in BMT nursing Respond to the changing educational needs of the nurses Promote recruitment and retention of staff Encourage nurses to specialise in the practice of BMT nursing Promote an environment where learning is a culture The educational programme structure includes:
Competency -based learning Supervised practice Individual and group teaching sessions Rolling teaching programme Formal study days Clinical supervision The programme is lead by the BMT Clinical Nurse Specialist with signifi cant involvement from other members of the multidisciplinary team. The poster gives a more detailed insight into the Oxford BMT nurse education programme.
• Thomas' NHS Foundation Trust (GSTFT) and also about the EBMT (UK) NAP. As part of the fellowship I was asked to choose a service development project and to present it to the 38th EBMT (UK) NAP forum in York. At GSTFT the apheresis service carries out approximately 300 apheresis procedures per year and due to high staff turnover as well as regulatory requirements a new training and competency package needed to be developed. Over a 6 month period I developed the competencies for peripheral blood stem cell collection (PBSC), therapeutic plasma exchange (TPE), and red blood cell exchange (RBCX). During this process we also updated our standard operating procedures for Training and Competencies and different apheresis procedures. These documents were submitted to the Hospital approval process to ensure clinical governance requirements were met. The full training programme includes standard presentations on blood component theory as well as workbooks by the manufacturer and supervised clinical practice. The training is supported by designated mentors for each trainee. The Apheresis Training & Competency Programme is now underway and the fi rst nurses to be assessed using the new process and documentation are to be assessed by the end of the year. Furthermore, the team is looking at developing a process for annual competency assessment to ensure apheresis nurses are skilled and are prepared to face any possible challenges.
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Coping with multi-lingual and multi-cultural patient population in BMT unit I. Mahmid Sourasky Medical Center (Tel Aviv, IL) Background: The high quality of medical care in Israel has turned it into an attractive site for medical tourism. As a result, an increasing number of foreign patients from different countries are being treated in our outpatient clinic in the recent years. Thus, proper communication with the patients became an increasing problem for our nursing team. Such patients may be unable to clearly communicate their fears, problems and symptoms and may not be able to follow the instructions and recommendations. The nursing team on the other hand, faces diffi culties in providing the patients with important information regarding signs and symptoms to be reported. Aim: Our goal is to improve our communication skills with the patients and their families to improve the quality of treatment in transplanted patients. Method: In this paper we will explore the obstacles the patients face and how we can improve the interaction between the patients and the nursing staff: 1. Acquisition of cultural competence by the staff 2. Preparation of educational material in several different languages 3. The use of professional translators. Professional translators are indispensable in understanding symptoms, providing and accurate patient history, communication instructions about medications and discussing treatment options. A professional translator who is considered an active part of the medical team may also be able to translate subtle cultural information as well as words. Conclusion: In a multi-lingual and multi-cultural environment, acquisition of communication skills and cultural competence by the nursing team in BMT units is necessary to maximize health outcomes for individual patients and their families.
P1398
Baby-apheresis: nursing aspects of stem cell apheresis in very young infants illustrated by a case report O.T. Bank VU Medical Center (Amsterdam, NL) Introduction: Stem cell apheresis in very young infants, particularly below 10 kg, is rare, because of limited indications. Intensive care monitoring is necessary and special nursing skills are required. Case report: A 9 month old infant of 7 kg was diagnosed with a stage IV neuroblastoma and treated according to the NB2004 protocol. After 3 cycles of chemotherapy the tumor response was favourable.The mobilization of stem cells was performed out of the 3rd chemotherapy cycle by subcutaneous injection of G-CSF. After 5 days CD34+ cell content of the peripheral blood was determined to be able to plan the start of the leukapheresisprocedure, which was started on the 7th day. Discussion: Specifi c problems and complications are faced during apheresis in young infants:
Hypocalcaemia: the patient cannot make clear when citrate toxicity (such as cramps and tingling) occurs. Therefore strict monitoring of (ionized) calcium is necessary, at least every hour, and prophylactic treatment with intravenous calcium is indicated aiming at the upper normal values. In the very young, specifi c attention should be given to minor changes in behaviour of the child (such as agitation, defecation, groping of nose and mouth). Hemodynamic control: The extracorporal space (tubes and containers) of the machine (Cobe Spectra ® ) is 284ml. This implies for young children, that up to 1/2 of the total blood volume could be outside the body. Before the procedure starts, the machine must be primed with reconstituted blood, a mixture of erythrocytes and plasma. The total blood volume will be processed 2 to 3 times by the machine, depending on the progress that is being made. Specifi c attention is paid to venous access: despite low bodyweight a good sized catheter needs to be inserted. In very young children general anesthesia is required because their liveliness stands in the way of an effi cient stem cell collection.
Hypothermia: Priming of the leucapheresis machine is performed with pre-heated blood (37°C). During the procedure constant temperature monitoring is needed. If necessary an electrical blanket ("bear hugger") can be used. Monitoring of platelets after the procedure is mandatory because of trapping in the machine during the procedure. To be able to adress all above mentionned problems, this procedure should be performed in the intensive care unit, with careful monitoring. Moreover, a team consisting of two leucapheresis operators, nurses and physicians of intensive care, hematology and pediatrics is required. It is important that the whole team is ready to be able to start the procedure if CD34+percentage is suffi cient. Conclusion: For apheresis in the very young infant, a good preparation is crucial. The procedure should be performed in the intensive care unit, with a multidisciplinary team, for adequate monitoring of and response to changes in hemodynamics, body temperature and calcium metabolism. At one year post-allogeneic stem cell transplant,if there are no on-going transplant related issues,i.e.,graft versus host disease, our patients are transferred to the long term follow up clinic. As part of our screening and preventive standard operating procedure for survivors, there is an assessment for potential liver complications. One such test is the measurement of serum ferritin levels. Ferritin is a protein present in cells that stores excess iron for the body. A small amount is released into the blood and by testing ferritin levels the total amount of iron stored in the body can be determined. Excess iron will accumulate in the liver, spleen and bone marrow, but also in the pancreas, joints, thyroid gland and the heart, potentially causing damage in these organs. Patients often complain of non-specifi c symptoms such as tiredness, weakness, weight loss, abdominal and joint pains. In the post allogeneic transplant population the cause of elevated ferritin is the result of multiple blood transfusions both pre and post procedure. One unit of transfused blood contains 200-250 mg iron. It is therefore important to always transfuse blood appropriately to this population both from a cost-effective perspective and in the context of national blood shortages, but also in the management of late effects. All patients will have a baseline ferritin level measured pre-transplant (normal level 24-336g/l). Our institutional practice based on the European Group for Blood and Marrow Transplantation (EBMT) guidelines is to initiate a venesection programme if one year post transplant ferritin levels are >1000 and to continue until <1000. Venesection is the removal of approximately 500 mls blood per session. One venesection removes 1 gm of iron. It is performed by inserting a large bore kimmel needle into a peripheral vein and attaching an anti-coagulated collection bag. This process is the same as used for healthy donor blood donation. It is performed by nurses in the ambulatory care unit, usually at monthly intervals. This is an overview of 5 patients, treated with venesection in our unit. Demographics: 4 male: 1 female. Age range 23-66. Pre-transplant ferritin level range: 1161-3620. Post-transplant ferritin range: 1428-4500. Average number of venesection sessions needed: 6 (range 5-10) Side-effects observed in this patient group and common for this procedure and which require nurse management: anxiety, needle-phobia, diffi cult intravenous access, hypotension, and syncope. The study addresses standard B4.10 'The Quality Management Plan shall include, or summarize and reference, policies and procedures for detecting, evaluating, documenting, and reporting errors, accidents, suspected adverse events, biological product deviations, and complaints' The aim was to assess the different methods of managing risk and adverse events (A/E) in 3 BMT transplant programmes. The poster describes the three A/E reporting systems which have been implemented to meet the JACIE standard and manage BMT specifi c incidents at local level. In addition each hospital has an existing hospital wide incident reporting system (IRS). Two centres undertake transplant, collection and processing, one undertakes autologous transplant only. The centres are at a different stage of JACIE accreditation; one is accredited and two are prior to accreditation, one having applied for inspection. The implementation and outcomes of the three A/E systems were compared. Differences were found in the methods of reporting the incidents and the types of meetings where A/Es are discussed. Despite these and other differences in implementing the standard, there are similarities in outcome including the increased speed in reporting, discussing and actioning incidents at a local level and the visibility of the system in undertaking and closing actions. Despite the A/E systems being a second method of reporting incidents with potential for duplication and confusion with Trust systems, they appear to be utilised effectively and appropriately; running in parallel and with links to the existing IRS where necessary. Outcomes: A dedicated local group having regular review and discussion of incidents with proactive management of incidents and potential A/Es building continuous improvement. Actions on minor incidents that may not have been reported/ discussed at the hospital IRS. Increased communication between each of the part of the programme. Managing and closing actions through regular review. A/E actions cascading to other areas of the QM system e.g. the development of processes, training and operating procedures. Requirements met for other accreditation bodies.
In conclusion, implementing JACIE standard B4.10 has stimulated the development of pragmatic, complimentary and tailored A/E systems resulting in clarity and effectiveness in the management of incidents thereby maximising patient (and staff) welfare.
P1401
Cord blood collection system in the paediatric haemato-oncology department I. Porat, R. Ofi r, M. Ben-Arush, I. Zaidman Meyer-Children Hospital Rambam Medical Center (Haifa, IL) Umbilical cord blood (u.c.b.) has a high capacity to renew the circulatory and immune systems and therefore is a good source for bone marrow transplants. Due to the increase in the number of and expanded indication for u.c. transplants, we decided to build a cord blood collection system in the children's Hematoncology department, providing families of patients the opportunity to use this procedure. As the collection process is complex and requires many evaluations by the staff and by the parents and families of the sick child, construction of the program within the hospital was important to insure availability and concentration of services. The transplant coordination nurse was designated as the coordinator for the collection process. At the beginning of construction of the program, we identifi ed the factors involved in the process via a fl ow chart that lists the collection system participants. In order to organize the collection process, an appointment was set up with delivery room teams to defi ne a clear work procedure and with the laboratories to set up work regulations which included submitting the mothers information and estimated delivery date, collection availability of laboratory employees for 24 hours in order to receive the blood, and medical standards for the preservation and freezing of blood. A form was built for blood tests identifying in the mother HIV, Viral Hepatitis, and Syphilis. Collection involves several steps: -Detecting a potential mother. -Meeting with the mother, collecting relevant information, explaining the procedure to her, acquiring informed consent on how to collect, freeze, and store the blood.
S444
-Contacting the doctor to obtain a commitment to preserve and freeze c.b. -Contacting the laboratory and submitting relevant information Before birth the mother is equipped with a sealed set to collect the blood. The mother contacts the nurse coordinator that runs the system and informs here that she is in the delivery room. As c. b preserving is relatively new among birth couples, c. b counseling is given in the community to pregnant women that are interested, in order to ensure "maximum medical protection" for their newborn and to increase the blood storage supply in the country. There is great signifi cance in c. b. collection and preservation, as c.b can bring new life for children with cancer and children with other genetic diseases.
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Monitoring of perceived quality of life of family and patients, who underwent transplant: experience of a single Italian centre G. Cusumano, T. Gangemi, M.G. Monorchio, M. Scirtò, T. Trimarco, S. Ipek, G. Campolo, N. Meliambro, L. Russo AO Bianchi Melacrino Morelli (Reggio Calabria, IT) Introduction: Since 1999, our Centre has developed the project "Quality Assurance", through the monitoring of perceived quality, commonly known as customer satisfaction. This defi nition is understood as the personal assessment of the patients and his family on the degree of satisfaction during the period of transplant. Aim of the study: To improve the standard of quality medical and nursing care and the logistic system. The project "Quality Assurance" implied a complete overhaul in our operative procedures and processes and the results will be developed in a "quality manual" involving the activities of the clinical unit, day hospital (DH) and laboratory. Method: The project includes the distribution of a specifi c questionnaire, set up with the collaboration of a pool of psychiatrists of our hospital and addressed to the patients admitted to the clinical units, the DH patients and their family. The questionnaire is anonymous to guarantee the truthfulness of the answers. The questions are focused on quality accommodation (rooms, food), nursing and medical care, attention to privacy, effi ciency of equipment and access to the Center's service. Result: From January 1999 to January 2010 were evaluated n.5112 questionnaires, completed by the three groups of customers. The critical points were mainly the quality of food and premises, the diffi culty in telephone contact with the Centre. The appreciation of nursing care has always been relatively high except for a single year (2006), because of some negative reports about certain behaviors of nursing staff, readily solved in the same year. The medical care has constantly received high approval rating. Conclusion: The continuous and careful monitoring of the patients' assessment and the use of the questionnaires as suggestions to improve our organization is a useful tool to understand defi ciencies not easily understandable and perceived by the clinical team. The annual evaluation of questionnaires allowed the correction of some defi ciencies and helped to maintain and increase the quality of global care, thanks to the corrective actions taken. The confi rmation of the achieved success is the increasing positive opinion in the recent years.
P1403
Results of a survey inviting (prospective) haematopoietic progenitor cell transplant recipients to respond E.H.M. Van Hoef Transplant Creations (Amsterdam, NL) Introduction: In the context of our focus on treatment by hematopoietic cell transplantation as part of therapy a questionnaire was developed to offer patients visiting the website or a link at public sites to respond. Method: A survey was prepared containing 20 questions, 6 related to general responder characteristics, 10 to autologous and allogeneic transplantation, and 4 to donation of bone marrow, interest in education about transplantation and donation for clinical research or treatment by transplant. All yes/no questions also had the option not applicable or uncertain. The results were analyzed as % of all responders and % of responders to a question. Herein we present as % of responders to a question. Results: As of August 2009 68% of 107 responders completed the survey, 100 could read dutch and 7 fi lled out the english version. 70% were women. 49% were patients, 27% family members, 24% were neither patient nor family member. 22% had leukemia, 9% lymphoma, 12% multiple myeloma, 27% breast cancer, 16% another type of cancer and 15% had no cancer. 46% had developed cancer in past three years. 27% had spoken with their doctor about autologous and 26% about allogeneic transplant. 11% had been treated by autologous and 12% by allogeneic transplantation. 35% were interested to receive more information about transplantation. 78% was aware that bone marrow can be donated. The cost estimate was in all but two cases far below the actual costs of the procedures. Only 3% of responders was interested to make a donation to support research in transplantation and 36% were uncertain. Discussion: Herein results are shown of part of responses to a website survey motivating patients to participate in the program. Through time 107 people have responded and only 49% were patient. This is a small percentage of patients who have seen the invitation to respond either at the website or a public site. Bone marrow transplant should become better known as treatment option in particular among recently diagnosed patients.
P1404
2009 A/H1N1 infl uenza pandemic: multidisciplinary logistics of vaccination campaign for HSCT recipients R. Radiano, L. Dray, B. Bogorichin, R. Or, D. Engelhard Hadassah Medical Organization (Jerusalem, IL) Introduction: As infl uenza may cause severe and complicated disease, with up to 15% mortality, in hematopoietic stem cell transplantation (HSCT) recipients, the 2009 A/H1N1 infl uenza pandemic presented a potential threat for our HSCT recipients. Following the intensive actions that were taken by the Israeli health authorities to prepare for a potential A/H1N1 infl uenza pandemic, we strongly recommended that our patients be vaccinated as soon as the vaccine became available. Therefore, our departments aimed to launch an operation of vaccinating our outpatient HSCT recipients: as many as possible -as soon as possible. Methods & Intervention: A multidisciplinary steering committee was gathered and a multi-stage fl owchart was established regarding: recruitment and timing coordination, patient education and compliance issues, detailed anamnesis, vaccination procedure-documentation, follow-up and informed consent, both for the 2 dose vaccination schedule and for joining the accompanied study. The study aimed to evaluate the antibody response to one-and two-doses of infl uenza immunization regimens with the vaccine; to compare immunity levels achieved after the fi rst and second doses and to analyze the relationship between the response to vaccination and baseline antibody titers and other clinical parameters. Results: Based on our regulated database an effective individual patient recruitment process was performed for the 2-step vaccination procedure. Patients recruited were >1 month posttransplantation and >10 years old. In 3 weeks during November-December 2009 we recruited 78 HSCT recipients for vaccinations, aged 11-72 years, 1-290 months post-HSCT. 55 (70%) were post-allogeneic HSCT recipients. 54 (69.1%) had active GvHD. Immune evaluation was performed on blood samples of 77 patients (98.7%) post-1st and of 43 patients (55%) post-2nd vaccination Conclusion: The possibility of this type of pandemic, which threatens the lives of post-HSCT recipients, presents the greatest challenge to the entire staff. As the nursing staff has advanced the logistics and multidisciplinary coordination within and among parts of the national medical establishment, the campaign refl ected thorough teamwork efforts towards maximizing the compliance for vaccination with high levels of quality care. The implementation of the vaccination operation may serve as a model for other emergency situations that require quick and effi cient multidisciplinary response.
P1405
Expansion of the oncology nurses' responsibilities in the bone marrow transplant department S. Torati, I. Sabah, N. Atar "Sheba" Medical Center (Ramat Gan, IL) In recent years there has been a change in the role of the head nurse in oncology wards. The head nurse has become a central axis connecting clinical and managerial aspects of patient care. A gap was identifi ed in our fi eld between the patient's clinical needs and the nurse's ability to provide better treatment. A way of bridging this gap is to transfer responsibilities from physicians to nurses. This, expands and empowers the role of the nurse, enhances her decision making process and improves overall effi ciency these should bring better satisfaction to both the patients and staff. We implemented this by establishing clinical protocols for the following : 1. Deciding to give and administering I.V magnesium to transplant patients. 2. Referring patients to chest X-rays following central line insertion. 3. Ordering and infusing platelets according to blood count results. Methods: Firstly, a program was created to enrich the nurses' knowledge on these topics. Then, a selected nursing staff wrote the protocols and passed them on for review and approval. Lastly, personal authorization was issued to each nurse before taking on these extra duties.A questionnaire examined the nurses' attitude towards their new responsibilities. its contribution to their own professional status, in addition to the patients' point of view and their satisfaction. Results: Twenty nurses responded to the questionnaire, average age 37.9 years, average work experience 8.5 years. Seventy three percent had the feeling that these new responsibilities improve their self esteem as oncologic nurses. Eeighty eight percent responded that patients' waiting time was shortened. Eeighty six percent believed that the quality of patient care improved. Thirty percent felt that these deter from the nurses' many other responsibilities. These fi ndings refl ect a heterogeneous attitude infl uenced by the nurses' age and years of experience. The younger nurses are motivated to promote their professional independence as opposed to the more experienced nurses that expect fi nancial compensation and try to preserve the existing conditions. In summary: our fi ndings highlight the place of the head nurse to initiate new work processes, criticize existing ones and bring all the elements together to lead the nursing team to independence and improve quality of treatment.
P1406
Hyperbaric oxygen therapy in haemorrhagic cystitis after allogeneic stem cell transplantation: nurse's role B.F.C.S. Pinto, L.C.S.G. Silva, C.A.G. Fernandes, F.B. Azevedo, C.M.B.F. Sousa Instituto Português de Oncologia do Porto (Porto, PT) Objective: With this work we intend to study the role of nurses in the care of patients with hemorrhagic cystitis (HC) submitted to hyperbaric oxygen therapy (HBOT). Material and methods: A refl exive approach over the nurse's role in the HBOT treatment in patients with severe HC. HC that occurs after allogeneic stem cell transplantations patients has a high morbidity. Polyoma virus (BK) and adenovirus infection are associated with late HC. The treatment of these conditions is conservative and essentially symptomatic. Specifi c treatments of these viral infections are not very effective. Chemical HC can occur early after transplant due to toxicity of high dose chemotherapy. HBOT has been used in the treatment of HC. This treatment is performed in a chamber that delivers 100% oxygen under pressure. HBOT causes vasoconstriction, promotes oxygen delivery to cells, reduces edema, promotes healing and has also bactericidal properties. In our center, severe HC patients are treated with HBOT. Between January 2005 and July 2010, 94% patients of a total of 16 with severe HC had their situation resolved (clinical, radiological and analytically) with HBOT treatment. All these patients had Polyoma BK viruria, adenovirus in urine was present in 6 and CMV in 3. Nurses have an active role in surveillance of these patients. Routinely, urine is visually inspected and a daily dip strip test is performed, which allows an early detection of microscopic hematuria. Also attention to early urinary symptoms enables nurses to increase awareness and alert physicians to this emerging problem. Nurses play also an important role informing patients that hydration is crucial at this stage. After established, HC has several important nurse's interventions, such as: use of bladder catheter, bladder irrigation, management of bladder catheter obstructions, evaluation of blood loss, transfusions, psychological support...when patients are referred to do HBOT the nursing's planning and action is fundamental. Conclusion: Nurse's care is of utmost importance not only in early diagnosis but also in the successful treatment of these patients.
P1407
Estimation of usage of central venous catheter with antimicrobial coating for prophylaxis of catheter-associated infections O. Ivanova, P. Kuga, Y. Oparina, M. Popova, I. Mushchitskaya, A. Lazarev, M. Bogomolnyj SPb State I. Pavlov Medical University (St. Petersburg, RU) One of the widespread forms of hospital infections are infections of blood circulation. Most of them are connected with usage of central venous catheter (CVC). Aim of the study: to estimate the specifi cs of central vein's cannulation for patients suffering from oncology and hematological diseases and to fi nd a way for minimizing catheter-associated infections (CAI). Task of the study: to estimate the effi ciency of Certofi x central venous catheter with antimicrobial coating for patients undergoing chemotherapy or bone marrow transplant (BMT); to calculate the duration of central venous catheter's usage; to defi ne the infl uence of CVC's lumina on CAI. Patients: 124 patients (pts) with different oncology and hematological diseases. 81 pts underwent BMT, 36 pts -chemotherapy, 7 pts -ECP therapy Age: 17-48 y.o. We divided pts into two groups: in the I group we used CVCs with antimicrobial coating (58 pts) and in the II group -without antimicrobial coating (66 pts). In all patients v. subclavia was cannulated with Introduction: In 2007 we studied the knowledge of and adherence to the nursing guidelines in our hematology ward by performing interviews and survey. The results showed insuffi cient application of the protocols in daily practice. Recently we established a working party with the objective to improve securing of the nursing guidelines, protocols and procedures in daily care of nursing. Method: The working party consisted of fi ve nurses from the hematology ward with special interest in quality of care. The well-known transparent method of Deming based on the plan-do-check-act (PDCA) cycle was applied. The PDCA was visualized for all nursing staff on a white board in the nursing conference room thereby stimulating the attention and continuous awareness between the nurses. In addition, performance indicators (PI) were developed to measure adherence to essential aspects of nursing guidelines, protocols en procedures. PI made an objective assessment possible. If the prescribed standards of 90% were not achieved, a plan was developed and implemented to improve the outcome. By measuring the PIs after the interventions we evaluated if the standards were achieved. We plan to monitor this in the future by measuring the PIs every two years. Developing and measuring PI is an ongoing project including various relevant subjects, in order to widely cover improving of this the quality of nursing care. Results: Until now we have developed and analyzed 26 different PIs covering nursing guidelines such as medication preparation and delivery to the patient and procedures concerning patient identifi cation. The evaluation before applying PDCA method showed the average PI value of 71%. After performing PDCA including the interventions average PIs level was increase to 86%. For example; before applying PDCA, PI for save delivery of medication described as "medication from patients are provide with a sticker which contains patient data" was 75%. After de implementation according, a second PI value increased to 90%. Conclusion: Applying the PIs and PDCA method improved awareness and responsibility among nurses concerning the quality of nursing care they give. Furthermore, increased application of guidelines, protocols and procedures in daily practice resulted in a higher quality of care. P1410 JACIE accreditation path: the perspective of an Italian nurse C. Soliman, V. Matozzo, N.M. Clercy, L. Callegaro, S. Marktel, A. Assanelli, F. Ciceri, C. Corti San Raffaele Hospital (Milan, IT) Background: In January 2008, our Hematology and Bone Marrow Transplantation Units received the ISO 9001 Certifi cation and in April, together with the Transfusion Medical Service, we started the preparation phase in order to request JACIE accreditation of the Transplant Program (TP). The process is not completed yet, the implementation of the documental system is nearly fulfi lled and the TP is waiting for inspection in 2011. The project involved all medical-nursing and technical staff; nurses acknowledged the accreditation as an important challenge for the quality improvement of patient care. Aim: The general aim is to reach the adjustment to quality and safety JACIE standards in clinical use, collection and processing of hematopoietic stem cells (HSC). The nurses standards include written procedures, a specifi c training program and formal experience in the management of adult and pediatric patients receiving HSC. The particular aim is to adapt the peculiar system of a mixed (adult and pediatric) TP to the JACIE standards. Method: We planned the working phases, the timing of evaluation and results publication. The operative frame is composed by task force delegates to design the organization chart and defi ne the TP. The procedures were written by 21 multi-professional groups chosen according to the JACIE standards topics. The groups arranged the work by planning periodic operative meeting. Results: The nurses became aware of the risk management: increased responsibility in reporting mistakes and in fi nding solution of problems in joint setting. The groups involved 9 nurses which carried out meetings twice a moth. The nurses wrote 21 procedures in collaboration with physicians and established a training program including hematology/oncology patients care; administration of chemotherapy, growth factors, immunosuppressive drugs and blood products; management of infections and intensive pediatric care. The mind-changing adaptation and organizational aspects were main diffi culties. Conclusion: The JACIE accreditation process represented for nurses an opportunity to improve quality and risk management and a helpful instrument for training, practice and clearing roles and responsibilities. The method allowed us to point out critical points and best solutions. The sharing of the teamwork promoted integration and reciprocal acquaintance. In the future, it is desirable to create an Italian specifi c training to recognize a formal role for nurses dedicated to the quality system.
P1411 Can nursing expertise be useful for a transplant coordinator? T.B. Soerensen Aarhus University Hospital (Aarhus, DK)
Aarhus University Hospitals bone marrow transplant unit has decided to employ a nurse as a transplant coordinator. An alternative option could be an administrative employee. The coordinators responsibility is to prepare the patient for transplantationto coordinate all problems related to the patient from the pre-admission assessment to the date of transplantation. The job includes informing the patients and rela-tives, planning pre-transplant examination, coordinating patients and donors' schedules and transpor-tation of stem cell product. The huge number of practically and organizational tasks are often in focus but the coordinator has many interdisciplinary collaborators which need medical information. These are probably better answered by a nurse. The physician and the coordinator have one common guideline for the clinical pathway which describes all details from the patient is enrolled in a transplantation program to the transplantation is completed. The guideline prescribes all the physicians and nursing tasks, and the coordinator has check lists which for example contain information and screening for nutrition problems, for economical, social and family prob-lems, need for physiotherapy and specialized nursing. Being a nurse with fi rm knowledge on hematological care and treatment makes it possible for the coordinator to:
Provide more precise information and instructions to patient and relatives about care and treat-ment identify need for care, obtains information with importance for care and makes notes in the nurs-ing part of the medical record better observe, predict and then maybe prevent some complications associated to transplantation better obtain and asses medical information from patient and collaborators better supply applicable information to physicians and nurses in transplant ward better answer medical questions from patients and collaborators
The result is that the coordinators skills as a nurse are visible for patients and collaborators, which urge them to involve her in all problems and makes it possible to have a complete overview of the clinical path-way. Besides, the nursing part of the job is not given a lower priority than the administrative tasks. The conclusion is, that employing an experienced nurse as a transplant coordinator and having a guideline contending specifi c nursing tasks increase the overview, the coherence and the continuity for patients collaborators. Plerixafor combined with G-CSF is increasingly used for autologous stem cell mobilisation. Plerixafor must be administered 10 to 12 hours prior to stem cell collection. Thus, a close coordination between the stem cell collection facility and the hematology department is mandatory. Between Feb. 2009 and Oct. 2010, 44 patients (lymphoma, myeloma) in our centres were deemed eligible to receive Plerixafor for autologous stem cell mobilisation. This report describes from a nursing perspective, the management plan established to optimize and ensure success of the Plerixafor-based mobilisation procedures. Among these 44 patients, 23% received Plerixafor frontline because they were considered during the multidisciplinary meeting as "predicted poor mobilizers". On the other hand, 43% of these 44 patients received Plerixafor after failure of a fi rst mobilisation procedure. In the remaining 24% of patients, Plerixafor was administered on a "pre-emptive basis" given the fact that these patients had a very low number of circulating CD34+ stem cells on the fi rst day of aphaeresis, precluding the performance of a successful stem cell collection. In order to handle effi ciently the above different scenarios, the nursing team established specifi c operating procedures aiming to organise patients' information in due time, hospitalisation and administration of Plerixafor. In the fi rst two scenarios, patients were informed during a visit to the outpatient clinic that they will need to be hospitalised for Plerixafor administration. In the context of the third scenario (pre-emptive administration), the coordinating nurse had to organise a "same day" consultation with the patient to explain the procedures related to the use of Plerixafor and organise hospitalisation. Implementation of these operating procedures highlighted several challenges that the team had to handle. From the patients' perspective, there was a crucial need to sensitively manage the patients' "feeling of failure" since they needed a salvage treatment for stem cell mobilisation. From the hospital perspective, we had to arrange for a "same day" hospitalisation in the context of bed shortage in a public hospital. In all, we conclude that creation of new organisational tools and close cooperation between the clinical units and the aphaeresis department allowed for an effi cient and successful implementation of the use of Plerixafor.
P1412
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Discharge management in the stem cell transplantation unit of the University Hospital Zurich, Switzerland L. Bircher, M. Guerra-Holze University Hospital Zurich (Zurich, CH) After hematopoietic stem cell transplantationpatients demand a structured and well-organized discharge from the hospital. Importantly,the discharge should take place whenever possible at the arranged date and time andall necessary informations and documents should beready. Likewise, the ensuing caregivers should be suffi ciently informed and prepared for the further treatment of the patients. By that, the structured discharge management may not only improve the patient's satisfaction, but also serve the hospital structures.In particular, it may help to reduce the duration of hospitalization and therefore may have economical implications in the hospital management. Since 2009, we established in the stem cell transplantation unit of the University Hospital Zürich a structured computer-based discharge management. Before that, the patient' discharge was managed by a variety of paper forms. After the introduction of the electronic discharge management, a series of improvements were implemented in the electronic version. The structured discharge management aims towards a holistic approach and integral medicine. It primarily aims to give the patients the feeling of security regarding their forthcoming discharge from the hospital. With an optimal discharge management starting at the day of hospitalization, it secondarily aims to avoid unnecessary prolongation of the hospital stays and provide an optimal continuation of the treatment after hospitalization. The patient' history on admission is assessed by experienced nursing staff. During hospitalization, the assumed status of patient is constantly evaluated. With this information the necessary support at the time of discharge can be estimated more accurately. It is equally important to involve early in the course the relatives of the patient as well as interdisciplinary services. All these measures help to improve the structured patient's discharge. The effect on the patient's satisfaction and the current standard of care was assessed by a structured questionnaire. It contained questions to various quality aspects of the transplantation unit. The questionnaire was sent to patients and caregivers of the HSCT unit. A study comparable to ours already exists from Verein Zürcher Krankenhäuser. We have adapted some questions out of this survey and included them in our questionnaire. The results of the questionnaires are currently evaluated and the fi nal results of the analysis will be presented at the meet. Background: Scotland has a large geographical area but most of the population is concentrated in Glasgow region. Haematology departments outwith the Glasgow area currently transfer selected patients to the Beatson West of Scotland Cancer Centre in Glasgow to undergo Volunteer Unrelated Donor (VUD) Stem Cell transplant.Post transplant patients will recieve follow up care at their local Haematology Department in addition to the follow up appointments they attend in Glasgow. Aim: The aim of this project is to review the post transplant experience for patients who have had a VUD Stem Cell Transplant but who live a distance. The service at both their local Haematology Department and Glasgow is evaulated. Key focus for the project is to identify the challenges associated with travelling and to look at areas for potential improvement.
Quality of life
Research method: A qualitive study, with a sample of 14 individuals who have had a VUD transplant. This represented a homogenous sample and provided a large amount of data to analyse. The method used was a semi-structured interview and a prepared information sheet was given to the selected individuals. With the consent the researcher returned and scheduled interviews took place. Grampian Research Ethics Committee were contacted to gain approval to undertake the study. They indicated that full ethical approval was not required as it was deemed to be a service evaluation project. Findings: Fourteen interviews ere undertaken and data analysed using Miles and Huberman's qualitive analysis approach. The main fi ndings to emerge from the study include attendance and location of the post transplant review clinics resulting in several hours of travel, at a time when patients may be experiencing challenging symptoms.There is a suggestion that the clinic visit is sometimes very short compared to the excessive journey time. The resulting fi nancial and personal social factors can impact on patients and their families experience. Some patients feel there are similarities in the information and assessment they recieve. References available and poster to back up fi ndings will be provided.
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One profession -Two worlds of employment -One aim I. Gruber St. Anna Children Hospital (Vienna, AT) My tasks and experiences as a paediatric nurse caring for a rehabilitation camp for children and teenagers after cancer treatment Since 25 years I am qualifi ed as paediatric nurse at the St. Anna Children Hospital stem cell transplantation-unit. An exciting but challenging profession. Everyone who works in it, has announced that after a hospital stay-of the daily life of patients is still far away from commonplace. Allthough we often expect that children return quickly to their normal life after successful treatment, the way back is quite stony for the whole familie. They are fare beyond their expectations and the burden of late effects is still present. The "national organization for children's cancer care" aims to assist patients and their families with reintegration. The "rehabilitation camps" play a centrale role and offer tailord programs for the needs of various age groups. The professional team of educators, psychologists, psychotherapist, and a paediatric nurse offer the children a platform of a well-prepared 10-day-game history to exchange experiences and disease specifi c. For this purpose I was trained as a leisure educator for one year to accompany these camps. My duties at the camp are medical treatment, supervizing and supporting the children with nursing measures. (e.c. subcutane application of growth hormones) Minor "accidents" are fi rst aided from me, and I indicate a doctor's visit. The work outside the hospital is much joy and motivation for me. It's nice to see how they make their own progressions during the post-care-camp after a long and serious illness by making experiences to handle a change in living conditions. We trie to show them posibilities of ways back from the daily routine to self-determination. One of the majorgoals is not only but also teamwork within the peer group handling the daily routine. I want to point of the importance and effectiveness of aftercare camps, and aware of all concerned groups of professionals. For me, working in a rehabilitation camp is a very satisfactory enrichment and it infl uenced my personal attention in the stationary everyday anew.
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Oral chronic graft-versus-host disease after allogeneic stem cells transplantation: clinical characteristics M. Marxova, J. Suvova, E. Bystricka University Hospital (Pilsen, CZ) Introduction: oral chronic graft versus host disease (GVHD) is a signifi cant complication after allogeneic stem cells transplantation. There is no consistent information about this complication Introduction: One of the complications, usually known in nonrelated allogenic transplants, it's the graft against the host disease, which may occur since the fi rst days until the next two months after the transplant, being considered the major cause of morbidity and death. The occurrence depends of the histocompatibility level, number of T cells in the graft, age of the patient and prophylactic regime. The affected organs are the skin, the intestine and the liver. The gravity depends of the clinic stage. It's graduation goes since level I and II of low morbidity and levels III and IV being the ones with more mortality risk. A prophylaxis with the immunosuppressive therapeutics can reduce the transplant patient's risks, inherent of the graft.
Objective: This study characterizes the use of the rabbit Timoglobulina of the Genzyme in patients submitted at the TMO non-related of different diagnosis and the incidence evaluation of the GVHD. Methodology: The study occurred between the period of April 2009 and November 2010, the conditioning regimen was made according the Medular Transplant protocol. It evaluated 10 patients, 5 men and 5 women, in the age between 13 months and 43 years old, with aplastic anemia, leukemia and myelodysplastic syndrome. The conditioning consists in the cyclophosphamide (Cy 60 mg/kg for 2 days); Bussulfex (Bu 0,8 mg/kg x 16 doses) and Timoglobulina (ATG 5.5 mg/m² being administrated in the days -3;-2 and -1 with possible adjustments in the doses.
Results: Was possible to see that the blockage of the T lymphocytes activation strategy and the removal of the T lymphocytes of the infused bone marrow, results in a substantial decrease in the severity of the (DECH), by monoclonal antibodies, glucocorticoids, cyclosporine, tacrolimus, methotrexato and mycophenolate mofetil, as immunosuppressive therapeutic. Concomitant the patient conditioning, its extremely important the interaction of the multidisciplinary team and the discussion of the clinic evolution in each treatment, being the nurse team responsibility for the vigilance control of the vital parameters associated to the chemotherapy ,effects and adverse reactions in the monoclonal antibodies administration during the period of hospitalization.
Conclusion: The rabbit Timoglobulina (ATG) usage can reduce the graft incidence in the stage of graft rejection of its host and increase the patient's life probability after the transplant.
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Assessment of oral mucositis: comparative study A.R. Pinto Marques, A.P. Branco Santa Maria Hospital (Lisbon, PT) Introduction: Oral mucositis is caracterized by infl ammation and ulceration of the oral cavity, and its integrity adversely affected by chemotherapy. Oral mucositis may have a substantially negative outcome such as infection, thereby reducing the quality of life of patients. A severe mucositis can lead to an increase in length of hospitalization, the use of feeding tubes, parenteral feedings, which can increase costs for drug treatment and even death cases. Knowing that, oral mucositis is one of the most common side effects of therapy and debilitating anti-cancer and affects patients undergoing chemotherapy and radiotherapy lasting for a period of 6 to 8 weeks. This arises the need to integrate a solution that beyond the control of mucositis, can also act as prevention. This solution Caphosol, supersaturated solution of calcium phosphate that helps maintain the integrity of the oral cavity, preventing the occurrence of oral mucositis and morbidity associated with it.
Since the Caphosol has an essential role in maintaining the integrity of the oral cavity, we felt the need to implement a study in order to reduce the oral mucositis. Appears to us then the hypothesis to study in our unit, this new product compared to what we already used, for the same purpose. The aim of the study is: -verify the effectiveness of caphosol in the prevention and treatment of oral mucositis in patients undergoing chemotherapy -To fi nd a tool and procedure for mouth care Methodology: The study is quantitative, comparative, retrospective and exploratory nature, conducted in 20 patients who underwent conditioning with chemotherapy and performing haematopoietic stem cell transplantation. It was conducted between February and June 2009 and 10 patients were selected to rinse their mouths with the solution Caphosol and 10 patients with sodium bicarbonate solution. Throughout the study period was assessed the degree of oral mucositis (according to the Wold Health Organization scale), the need for parenteral nutrition and for analgesic medication. Conclusion: According to the results it was concluded that, patients who used caphosol showed a reduced degree of oral mucositis as well as reduced need for analgesic medication and parenteral nutrition. We can conclude that caphosol is more effective. Thus, we hope to have contributed to the improvement of patient care Hemato-Oncology, through the sharing of new knowledge.
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Spiritual care as a part of comprehensive care for haemato-oncological patients M. Cermáková, I. Rehorová, V. Ilemová General University Hospital in Prague (Prague, CZ) Introduction: Access to hematooncological patients must be holistic. The patient's biological, psychological, social and spiritual needs must be satisfi ed. Satisfaction of all these needs affects the quality of life. In our department we provide the best possible care and therefore saturate all of the above-mentioned needs. We recognized that staff also need spiritual care as well because staff also has psychological and spiritual needs. Therefore we have a hospital chaplain who serves inpatients from our department. The chaplain is a member of the multidisciplinary team who care for the patients. Chaplain's being member of the multidisciplinary team is not common in the Czech Republic.
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Objective: To achieve the highest quality of care and the good quality of life for patients. Method: The patient's care is provided by a multidisciplinary team which is composed of physicians, nurses, lower medical staff and hospital chaplain. The hospital chaplain is present at the department three days a week visiting the patients and the chaplain is also available to the medical staff. The chaplain realizes about 30 visits a week. Most patients use the hospital chaplain's services since the beginning of the disease to autologous stem cell transplantation. The main topics of chaplain-patient conversations are sickness, family, sense of the patient's life, meaning of patient's current living situation. It helps the patients to see their lives from another view. Very important is that the chaplain is fully integrated into the multidisciplinary team therefore patients accept the spiritual care as a normal part of care even if the Czech Republic is very atheistic country. Close cooperation with the nurses is very important. Nurses are well-informed about the spiritual care and they are able to identify patients who need the spiritual care and they can appropriately offer the care to patient. Nurses also inform the chaplain about the needs of patients which makes this service more effi cient. Conclusion: Thanks to providing spiritual care as a part of comprehensive care is the environment of our department friendlier to patients and nursing staff and the quality of life of the patients is higher. Background: In a recently published study we have reported patients' experience of their health related quality of life (HRQL) during auto-SCT. EORTC quality of life form, QLQ C-30 was used. Ninety-six patients were examined before, during and up to 3 years after auto-SCT. We found signifi cant differences between multiple myeloma (MM) and lymphoma patients' physical function, quality of life, fatigue and pain during week 2. MM patients experienced the same pain level as at baseline, but the lymphoma patients had signifi cantly more pain compared with baseline. The most probable cause of pain during week 2 was mucositis. Objective/method: In this study, we examined gender differences in the pain pattern in the 2 largest diagnostic groups during the fi rst 3 years. The study population consists of 56 MM patients (34 male and 22 female) and 32 lymphoma patient (22 male and 10 female). The data is processed from the main study.
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Results: The results show that women in the myeloma group estimates generally greater pain than men, especially at baseline and in week 2. Men and women in the lymphoma group have similar pain patterns. Age within each diagnostic group do not infl uence the pain estimates. Discussion: One explanation for the gender differences in pain in the MM group can be a result of hormone infl uences and liver metabolism. Another explanation can be that women have a higher risk of mucositis than men. However, no gender differences were seen in the lymphoma group. Conclusion: It is important to evaluate patients' pain by validated instruments in order to individualize pain treatment in daily care. Background: Disability (DI) is defi ned as reduction on ability to attend normal activities of daily living (ADL). Hematological diseases and their treatments cause a large variety of disabling conditions heavily affecting the Quality of Life (QoL). Moreover, DI may infl uence work load of caregiver, by requiring frequent interventions to satisfy patient (pt) needs. DI was rarely explored and reported in hematological patients undergoing hematopoietic stem cells transplantation (HSCT). We conducted a restrospective study among the seven Institutions participating in the Rome Transplant Network (RTN), a metropolitan transplant program, to assess DI during the period of HSCT hospitalization. Patients and methods: From September 2009 to August 2010, 230 HSCT were performed in RTN centres. Median age was 36,1 years old (0, 8) , 112 male and 118 female. Diagnosis was: acute leukemia in 80, multiple myeloma in 47, lymphoma in 64, solid tumor in 13, inherited disorder in 13, myelodisplastic / myeloproliferative disorders in 5, aplastic anemia in 5, other diagnosis in 3. 117 autologous and 113 allogeneic transplants were performed. DI was defi ned as a reduction of Barthel Index (BI), a multiitems broadly used scale, specifi cally addressing motor aspects of DI. BI items were assessed by nurse staff, through a non structured interview, pointed on the specifi c issues considered in BI scale. Results: Disability was observed in 137/230 HSCT (59%). Disability was mild (BI=67-99%), moderate (BI=33-66%) and severe (BI=0-32%) in 34 (15%), 63 (27%) and 40 (17%) patients, respectively. Severe disability was signifi cantly higher in pediatric patients: 21/66 (32%) <16 years vs 19/167 (11%) >16 years (p=0.0002) and in recipients of allogeneic transplant: 26/113 (23%) allogeneic vs 14/117 (12%) autologous HSCT patients (p=0.0025).
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Discussion: Ability and autonomy impairment are common features during cancer therapy and HSCT. Our retrospective study demonstrates that disability in HSCT is a frequent complication, with 59 % of patients experiencing some grade of disability during procedure. Conclusions: Our data allow to identify risk categories of patients, for whom preventive, anti disability measures, should be preferentially provided . However, a prospective study on a large number of patients is required to better understand the total impact of disability on QoL .
Ethical issues
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Nursing teams treating BMT patients: attitudes and perceptions on transplantation E. Rom Tel Aviv Sourasky Medical Center (Tel Aviv, IL) Background: Nursing teams who treat patients that are undergoing BMT are exposed to an "aggressive" treatment which has both positive and negative consequences. From the beginning, nurses play an integral role in the whole process while making major decisions. They carry out an important duty in helping patients in crisis, and are involved along the whole BMT treatment process when a success or failure is the fi nal outcome. Therefore the main dilemma arising is whether BMT treatment is the optimal treatment going forward. Goals: To perform a wide range of self-perception towards the treatment To isolate the factors which affect the personal approach of the care team. To defi ne the major diffi culties which may inhibit the team in coping with treatment and its consequences. Methodology: A questionnaire was fi lled in by the nursing team in the ward, hematology and BMT outpatient clinic. The questionnaire consisted of 3 sections: Section 1 -Takes 4 different case studies describing different medical situations. The nursing teams were then asked to answer the questions on how they would treat the different scenarios if it was one of their relatives. Section 2 -The nurses were asked questions on BMT. They then had to rate each question on a scale, looking at the factors that infl uence them when they recommend BMT treatment. Section 3 -Looked at the professional and personal aspects of their job and how they see their self image in their current position. Results: From the fi nal results we could see that the inpatient and outpatient nursing team expressed a general discomfort with the BMT intervention option. Inpatient nurses reported on moral distress when goals of care were compassionate rather than curative. There was also a difference in attitude between inpatient nurses and outpatient nurses due to the complexity of care. Outpatient nurses are presented with a more optimistic and less agonizing view. Summary: Therefore we can see that an ongoing program is required to lessen moral distress from nurses performing BMT. Workshops for nurses may provide as a supportive tool cope mechanism. Medical teams and nurses must discuss difficult cases to help reduce the negative feelings and confl icts. In addition, the role of the nurse should be rotated between the inpatient and outpatient clinics, so that the experience of all phases of BMT and their acceptance of BMT intervention improves.
